SCIENTIFIC PUBLICATIONS:
BOOKS:
· Mease P, Khan MA (Eds). AXIAL SPONDYLOARTHRITIS. Elsevier 2020, ISBN: 978-0-323:56800-5, English, 294 pages.
· Khan MA: ANKYLOSING SPONDYLITIS-AXIAL SPONDYLOARTHRITIS. Professional Communications, Inc. (PCI). West Islip, NY. November 2016, pp. 1-333. ISBN: 978-1-943236-08-4
· Khan MA: ANKYLOSING SPONDYLITIS. Oxford University Press, New York, NY. 2009, pp. 1-147.
· Khan MA: ANKYLOSING SPONDYLITIS: THE FACTS. Oxford University Press, Oxford, UK, 2002; pp.1-193.
o Portuguese translation was published in 2004
o Japanese translation was published in 2008
o Persian (Farsi) translation was published in 2008
o Spanish translation was published in 2012
· Khan MA (Ed): ANKYLOSING SPONDYLITIS AND RELATED SPONDYLOARTHROPATHIES. Spine: State of the Art Reviews. Hanley & Belfus, Inc., Philadelphia, PA. September 1990.
Guest Editor:
· Khan MA: Ankylosing Spondylitis: Burden of Illness; Diagnosis, and Effective Treatment. J Rheumatol Suppl 2006; Sep;78:1-33
· Khan MA: Spondyloarthropathies. Rheumatic Disease Clinics of North America. Saunders, Philadelphia, PA. February 1992
Section Editor:
· Spondyloarthropathies. Opinion in Rheumatology. Lippincott Williams and Wilkins, from 1993 to 2001.
· Spondyloarthritis. Current Rheumatology Reports. Springer-Nature, since 2006.
Editorial Consultant:
· American College of Physicians’ on-line ACP Smart Medicine (formerly called Physician Information and Education Resource or “PIER”). Author of the chapter “Ankylosing Spondylitis” and its updates since from 2002 to 2015.
· InPractice Rheumatology, an on-line knowledge source for internists, and other specialists, including rheumatologists. Co-author of the chapter on “Spondyloarthritis” 2013 – 2016.
Other Publications:
|
Book chapters
|
50
|
|
Scientific articles
|
247
|
|
Letters-to-editor
|
37
|
|
Scientific abstracts
|
143
|
BOOK CHAPTERS:
1. Khan MA: Family studies in rheumatoid arthritis. In Dawkins RL, Christiansen FT and Zilko PJ (Eds.): IMMUNOGENETICS IN RHEUMATOLOGY, Amsterdam, Excerpta Medica, 1982, pp. 139‑141.
2. Khan MA: B27 and ankylosing spondylitis in different races. In Dawkins RL, Christiansen FT and Zilko PJ (Eds.): IMMUNOGENETICS IN RHEUMATOLOGY, Amsterdam, Excerpta Medica, 1982, pp. 188‑190.
3. Khan MA: Ankylosing spondylitis. In Calin A (Ed.): SPONDYLARTHROPATHIES, New York, Grune and Stratton, 1984, pp. 69‑117.
4. Khan MA: Spondyloarthropathies in non‑Caucasians. In Calin A (Ed.): SPONDYLARTHROPATHIES, New York, Grune and Stratton, 1984, pp. 265‑277.
5. Khan MA: How the B27 test can help in the diagnosis of spondyloarthropathies. In: Calin A (Ed.): SPONDYLARTHROPATHIES, New York, Grune and Stratton, 1984, pp. 323‑337.
6. Khan MA, Kushner I: Diagnosis of ankylosing spondylitis. In Cohen AS (Ed.): PROGRESS IN CLINICAL RHEUMATOLOGY, VOL. I, New York, Grune and Stratton, 1984, pp. 145‑178.
7. Khan MA, Kammer G: Laboratory findings and pathology of psoriatic arthritis. In: Gerber LH and Espinoza L (Eds.): PSORIATIC ARTHRITIS, New York, Grune and Stratton, 1985, pp. 109‑124.
8. Khan MA: Spondyloarthropathies in non‑Caucasian populations of the world. In: Ziff M, Cohen SB (Eds.): THE SPONDYLOARTHROPATHIES (ADVANCES IN INFLAMMATION RESEARCH, VOL. 9), New York, Raven Press, 1985, pp. 91‑99.
9. Khan MA: HLA and ankylosing spondylitis. In Calabro JJ, Dick C (Eds.): ANKYLOSING SPONDYLITIS‑NEW CLINICAL APPLICATIONS IN RHEUMATOLOGY, VOL. I, Lancaster (England), MTP Press Limited, 1987, pp. 23‑44.
10. Khan MA, Skosey JL: Ankylosing spondylitis and related spondyloarthropathies. In Samter M, Talmage DW, Frank MM, Austen KF, Claman HN (Eds.): IMMUNOLOGICAL DISEASES, 4th Edition, Boston, Little, Brown & Company, 1988, pp. 1509‑1538.
11. Khan MA, Reynolds TL: Genetische aspekte and HLA‑B27 bei der spondylitis ankylosans. In Fellmann N, Spring H (Eds.): SPONDYLITIS ANKYLOSANS MORBUS BECHTEREW, Bern, Verlag Hans Huber, 1989, pp. 48‑56.
12. Yamashita TS, Khan MA, Reynolds TL, Wolfe F, Stastny P: Familial rheumatoid arthritis: Genetic epidemiology of 75 white multi‑case families. In Dupont B (Ed.): IMMUNOBIOLOGY OF HLA, Vol II: IMMUNOGENETICS AND HISTO-COMPATIBILITY, New York, Springer‑Verlag, 1989, pp. 419‑420.
13. Stastny P, Olsen N, Pincus T, Khan MA, Ball EJ: DR4 and DR1 define different subsets of patients with rheumatoid arthritis. In Dupont B (Ed.): IMMUNOBIOLOGY OF HLA, VOL II: IMMUNOGENETICS AND HISTOCOMPATIBILITY, New York, Springer‑Verlag, 1989, pp. 418‑419.
14. Khan MA: Heterogeneity and a wider spectrum of ankylosing spondylitis and related disorders. In Lipsky PE and Taurog JD (Eds.): HLA‑B27+ SPONDYLOARTHROPATHIES, New York, Elsevier, 1991, pp. 133‑143.
15. Khan MA: Ankylosing spondylitis. In Schumacher HR Jr. (Ed.): PRIMER ON THE RHEUMATIC DISEASES, (10th Edition), Atlanta, Arthritis Foundation, 1993, pp. 154-158.
16. van der Linden SM, Khan MA: Spondyloarthropathies. In Wigley RD (Ed.): THE PRIMARY PREVENTION OF RHEUMATIC DISEASES, New York, The Parthenon Publishing Group, 1993, pp. 221-228.
17. Khan MA: Ankylosing spondylitis: Clinical features. In Klippel JH, Dieppe PA (Eds.): RHEUMATOLOGY, London, Mosby-Year Book Europe Ltd., 1994, pp. 3.25.1 - 3.25.10
18. Khan MA: Ankylosing spondylitis. In Rakel RE (Ed.): CONN'S CURRENT THERAPY, 1994 Edition, Philadelphia, W. B. Saunders Co., 1994, pp. 957-959.
19. Khan MA: Ankylosing spondylitis: Clinical features. In Klippel JH, Dieppe PA (Eds.): RHEUMATOLOGY, London, Mosby-Year Book Europe Ltd., 1995, pp. 211-220.
20. Khan MA, Wilber RG: Back and neck pain. In Bone R (Ed.): CURRENT PRACTICE OF MEDICINE, Philadelphia, Current Medicine, 1996, pp. VI:8.1-VI:8.14.
21. Khan MA. Prevalence of HLA-B27 in world populations. In Lopez-Larrea C (Ed.): HLA-B27 IN THE DEVELOPMENT OF SPONDYLOARTHROPATHIES. Austin, Texas, R.G. Landes Company, 1997, pp.95-112.
22. Khan MA: Spondyloarthropathies. RHEUMATOLOGY MKSAP (Medical Knowledge Self-Assessment Program), Second Edition, Developed by the American College of Rheumatology and the American College of Physicians, 1997, pp. 126-139.
23. Khan MA: Axial pain syndromes: Back and neck pain. RHEUMATOLOGY MKSAP (Medical Knowledge Self-Assessment Program), 2nd Edition, Developed by the American College of Rheumatology and the American College of Physicians, 1997, pp. 258-266.
24. Khan MA: Ankylosing spondylitis. PRIMER ON THE RHEUMATIC DISEASES, 11th Edition, Atlanta, Arthritis Foundation, 1997, pp. 189-193.
25. Khan MA: Ankylosing spondylitis: Clinical features. In Klippel JH, Dieppe PA (Eds.): RHEUMATOLOGY, (2nd Edition). London, Mosby-Wolfe, 1998, pp. 6.16.1- 6.16.10.
26. Khan MA: Seronegative spondyloarthropathies. In: Home HS, Feng PH (Eds). TEXTBOOK OF CLINICAL RHEUMATOLOGY, National Arthritis Foundation, Singapore. 1998, pp. 125-147.
27. Dougados M, Revel M, Khan MA: Management of spondyloarthropathy. In: van de Putte LBA, Williams HJ, van Riel P, Furst DE (Eds): THERAPY OF SYSTEMIC RHEUMATIC DISORDERS. New York, Marcel Dekker, 1998, pp. 375-406.
28. Khan MA: A worldwide overview - The epidemology of HLA-B27 and associated spondyloarthritides. In: Calin A, Taurog J (Eds.): THE SPONDYLARTHRITIDES. Oxford University Press, 1998, pp. 17-26.
29. Khan MA: Ankylosing spondylitis - The clinical aspects. In: Calin A, Taurog J (Eds.): THE SPONDYLARTHRITIDES. Oxford, Oxford University Press, 1998, pp. 27-40.
30. Khan MA: Spondyloarthropathies. In: Hunder G (Ed): ATLAS OF RHEUMATOLOGY. Philadelphia, Current Science, 1998, pp. 5.1 - 5.24.
31. Khan MA: Back and neck pain. In: Fitzgerald F (Ed.): CURRENT PRACTICE OF MEDICINE, 2nd Edition, Philadelphia, Current Medicine, 1999, pp. 187-203.
32. Khan MA: Ankylosing spondylitis. In: Rakel RE (Ed.): CONN'S CURRENT THERAPY, 1999 Edition, Philadelphia, W. B. Saunders Co., 1999, pp. 994 - 996.
33. Khan MA, McGonagle D. State of the art review: Pathogenesis of ankylosing spondylitis and related spondyloarthropathies. In Emery P (Ed.). FAST FACTS IN RHEUMATOLOGY Oxford, Health Press, 1999, pp.61-66.
34. Braun J, Sieper J, Khan MA. Recent Advances in Pharmacotherapy of Spondyloarthropathies. In: Tsokos GC, Kammer GM, Moreland LW, Pelletier J, Gay S. (Eds.). Modern Therapeutics in Rheumatic Diseases. Humana Press, Totowa, New Jersey, 2002, pp. 595-603.
35. Khan MA. Five classical clinical papers on ankylosing spondylitis. In Dieppe P, Wollheim FA, Schumacher HR (Eds.). CLASSICAL PAPERS IN RHEUMATOLOGY. Martin Dunitz Ltd., London, 2002, pp. 118-133.
36. Khan MA: HLA-B27 und seine Subtypen. In: Braun J & Sieper J (Eds.) SPONDYLITIS ANKYLOSANS. Unimed Verlag AG, Bremen [German Edition] 2002, pp. 64-69.
37. Khan MA: Spondyloarthropathies. In: Hunder G (Ed.). ATLAS OF RHEUMATOLOGY. 3rd Edition. Philadelphia, PA: Current Medicine 2002, pp.141–167.
38. Khan MA: Clinical features of ankylosing spondylitis: In: Hochberg M, Silman A, Smolen J, Weinblatt M, Weisman M (Editors). RHEUMATOLOGY, (3rd Edition). London, Mosby: A Division of Harcourt Health Sciences Ltd. 2003, pp. 1161-1181.
39. Khan MA, Sieper J. Reactive arthritis. In: Koopman WJ and Moreland LW (Editors). ARTHRITIS AND ALLIED CONDITIONS. (15th Edition), Lippincott Williams and Wilkins 2004, pp. 1335-1355.
40. Khan MA: Spondyloarthropathies. In: Hunder G (Ed.). ATLAS OF RHEUMATOLOGY. 4th Edition. Philadelphia, PA: Current Medicine 2005, pp. 151-180.
41. Akkoc N, Khan MA. Epidemiology of ankylosing spondylitis and related spondyloarthropathies. In: Weisman MH, Reveille JD, van der Heijde D. (Eds.), ANKYLOSING SPONDYLITIS AND THE SPONDYLOARTHROPATHIES: A Companion to Rheumatology. London, Mosby:- Elsevier: 2006, pp. 117-131.
42. Khan MA: Patient’s perspective. In: van Royen BJ and Dijkmans BAC (Eds.). ANKYLOSING SPONDYLITIS DIAGNOSIS AND MANAGEMENT. New York, NY: Taylor and Francis. 2006, pp. 95-97.
43. Elyan M, Khan MA. Spondyloarthropathies. CLINICAL CARE IN THE RHEUMATIC DISEASES. 3rd ed. Atlanta: Association of Rheumatology Health Professionals. 2006, pp. 177-185.
44. Khan, MA. HLA and spondyloarthropathies. Chapter 16. In Mehra NK (Ed). The HLA Complex in Biology and Medicine A Resource Book. Jaypee Brothers Medical Publishers Ltd. New Delhi, India. 2010: pp. 259-275.
45. Elyan M, Khan MA. Spondyloarthropathies. In Lin VW (Ed). Spinal Cord Medicine: Principles and Practice, Second Edition. Demos Medical Publishing, New York, NY. 2010: pp. 715-727.
46. Khan MA. Clinical features of axial spondylorthritis. In: Oxford Textbook of Acial Spondyloarthritis Inman R, Sieper J, eds. Oxford University Press, Oxford, UK. 2016: pp. 91-100.
47. Mease P, Khan MA. Introduction. In: Mease P and Khan MA (Eds.). Axial Spondyloarthritis. Elsevier, 2019, pp. 1-7.
48. Khan MA. Clinical features, diagnosis and outcome of axial spondyloarthritis. In: Mease P and Khan MA (Eds.). Axial Spondyloarthritis. Elsevier, 2019, pp. 9-29.
49. Akkoc N, Khan MA. Epidemiology of axial spondyloarthritis. In: Mease P and Khan MA (Eds.), Axial Spondyloarthritis. Elsevier, 2019, pp. 31-56.
50. Caballero-Uribe CV, Khan MA. Patient Education and Patient Service Organsations. In: Mease P and Khan MA (Eds.), Axial Spondyloarthritis. Elsevier, 2019, pp. 281-286.
SCIENTIFIC ARTICLES:
1. Ballou SP, Khan MA, Kushner I: Diffuse intervertebral disc calcification in primary amyloidosis. Ann Intern Med 85: 616‑617, 1976.
2. Khan MA, Kushner I, Braun WE: Comparison of clinical features of HLA‑B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 20: 909‑912, 1977.
3. Khan MA, Braun WE, Kushner I, Grecek DE, Muir WA, Steinberg AG: HLA‑B27 in ankylosing spondylitis: Differences in frequency and relative risk in American Blacks and Caucasians. J Rheumatol 4(Suppl. 3): 39‑43, 1977.
4. Khan MA, Kushner I: Improvement of rheumatoid arthritis following splenectomy for Felty syndrome. JAMA 237: 1116‑1118, 1977.
5. Ballou SP, Khan MA, Kushner I, Harris JW: Secondary gout in hemoglobinopathies: Report of two cases and review of the literature. Am J Hematol 2: 397‑402, 1977.
6. Khan MA: HLA‑B27 antigen and rheumatic diseases. Ohio State Med J 73: 619‑621, 1977.
7. Khan MA: HLA and disease. JIMA 8: 15‑17, 1977.
8. Flatuauer FE, Khan MA: Septic arthritis caused by Enterobacter agglomerans. Arch Intern Med 138: 788, 1978.
9. Ballou SP, Khan MA, Kushner I: Giant cell arteritis in a Black patient. Ann Intern Med 88: 659‑660, 1978.
10. Khan MA, Kushner I, Braun WE: A subgroup of ankylosing spondylitis associated with HLA‑B7 in American Blacks. Arthritis Rheum 21: 528‑530, 1978.
11. Khan MA, Kushner I, Braun WE, Zachary AA, Steinberg AG: HLA‑B27 homozygosity in ankylosing spondylitis: relationship to risk and severity. Tissue Antigens 11: 434- 438, 1978.
12. Lam M, Ricanati ES, Khan MA, Kushner I: Reversal of severe renal failure in systemic sclerosis. Ann Intern Med 89: 642‑643, 1978.
13. Khan MA: Chondrocalcinosis articularis (pseudogout): A study of 72 patients. JIMA 9: 9‑10, 1978.
14. Dejelo CL, Braun WE, Khan MA, Clough JD: HLA‑DR antigens and ankylosing spondylitis. Transplantation Proceedings 10: 971‑972, 1978.
15. Khan MA: Race‑related differences in HLA association with ankylosing spondylitis and Reiter's disease in American Blacks and Whites. J Natl Med Assoc 70: 41‑42, 1978.
16. Khan MA, Askari AD, Braun WE, Aponte CJ: Low association of HLA‑B27 with Reiter's syndrome in Blacks. Ann Intern Med 90: 202‑203, 1979.
17. Khan MA: Laboratory tests useful in rheumatological evaluation. JIMA 1 & 2: 5‑9, 1979.
18. Khan MA, Kushner I, Freehafer AA: Sacroiliac joint abnormalities in paraplegics. Ann Rheum Dis 38: 317‑319, 1979.
19. Khan MA, Kushner I: Ankylosing spondylitis and multiple sclerosis: A possible association. Arthritis Rheum. 22: 784‑786, 1979.
20. Khan MA: Recent advances in knowledge concerning genetic factors which predispose to rheumatic diseases. JIMA. 10:(No. 3 & 4): 4‑5,1979.
21. Khan MA: Clinical application of HLA‑B27 test in rheumatic diseases: A current perspective. Arch Intern Med 140: 177‑180, 1980.
22. Schoenberg LM, Kushner I, Khan MA: Concanavalin‑A induced transformation of mononuclear cells: Influence of plasma from patients receiving anti‑inflammatory agents. Proc Soc Exp Biol Med 164: 192‑195, 1980.
23. Khan MA, Kushner I, Braun WE: Genetic heterogeneity in primary ankylosing spondylitis. J Rheumatol. 7: 383‑386, 1980.
24. Khan MA, Khan MK, Kushner I: Survival among patients with ankylosing spondylitis: A life‑table analysis. J Rheumatol 8: 86‑90, 1981.
25. Khan MA, Kushner I, Braun WE: Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis. J Rheumatol 8: 295‑298, 1981.
26. Khan MA, Kushner I, Braun WE, Dejelo CL, Ballou SP: Clinical and HLA studies in multiple case families with rheumatoid arthritis. Tissue Antigens 18:136‑138,1981.
27. Khan MA, Ballou SP: Tendon rupture in systemic lupus erythematosus. J Rheumatol 8: 308‑310, 1981.
28. Ballou SP, Khan MA, Kushner I: Clinical features of systemic lupus erythematosus. Differences related to race and age of onset. Arthritis Rheum 25: 55‑60, 1982.
29. Khan MA, Khan MK: Diagnostic value of HLA‑B27 testing in ankylosing spondylitis and Reiter's syndrome. Ann Intern Med 96: 70‑76, 1982.
30. Thompson GH, Khan MA, Bilenker RM: Spontaneous atlantoaxial subluxation as a presenting manifestation of juvenile ankylosing spondylitis. Spine 7: 78‑79, 1982.
31. Hammoudeh M, Khan MA: Cranial arteritis as the initial manifestation of malignant histiocytosis. J Rheumatol 9: 443‑447, 1982.
32. Khan MA: Axial arthropathy in Whipple's disease. J Rheumatol 9: 928‑929, 1982.
33. Yagan R, Khan MA, Bellon EM: Spondylitis and posterior longitudinal ligament ossification in the cervical spine. Arthritis Rheum. 26: 226‑230, 1983.
34. Khan MA, Kammer G, Dejelo CL, Kushner I, Braun WE, Ballou SP: Study of HLA antigens in familial and sporadic rheumatoid arthritis. Tissue Antigens 21: 35‑38, 1983.
35. Hammoudeh M, Khan MA: Genetics of HLA associated diseases: Ankylosing spondylitis. J Rheumatol. 10: 301‑304, 1983.
36. Klein SM, Khan MA: Hepatitis, toxic epidermal necrolysis, and pancreatitis in association with sulindac therapy. J Rheumatol. 10: 512‑513, 1983.
37. Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease; rheumatoid arthritis. Tissue Antigens 22: 182‑185, 1983.
38. Jumshyd A, Khan MA: Ankylosing hyperostosis in American Blacks: A longitudinal study. Clin Rheumatol 2: 123‑126, 1983.
39. Yagan R, Khan MA: Confusion of roentgenographic differential diagnosis between ankylosing hyperostosis (Forestier's disease) and ankylosing spondylitis. Clin Rheumatol. 2: 285‑292, 1983.
40. Khan MA: B7‑CREG and ankylosing spondylitis. Br J Rheumatol. 22 (Supplement 2): 129‑132, 1983.
41. Miron SD, Khan MA, Wiesen E, Kushner I, Bellon EM: The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis. Clin Rheumatol. 2: 407‑414, 1983.
42. Mehra NK, Khan MA, Vaidya MC, Malaviya AN, Batta RK: HLA antigens in acute anterior uveitis and spondyloarthropathies in Asian Indians and their comparison with American Whites and Blacks. J Rheumatol. 10: 981‑984, 1983.
43. Raum D, Awdeh Z, Glass D, Kammer G, Khan MA, Coblyn JS, Weinblatt M, Holdsworth D, Strong L, Rossen RD, Brewer E, Yunis E, Alper CA: Extended haplotypes of chromosome 6 in adult rheumatoid arthritis. Arthritis Rheum. 27: 516‑521, 1984.
44. Khan MA, Khan MK: HLA‑B27 testing in the diagnosis of spondylitic diseases. Intern Med Specialist. 5: 55‑65, 1984.
45. Khan MA: Temporal arteritis and polymyalgia rheumatica. Signs of giant cell arteritis. Pak J Ophthalmol. 1: 33‑36, 1984.
46. van der Linden SM, Khan MA: The risk of ankylosing spondyltis in HLA‑B27 positive individuals: A reappraisal. (Editorial) J Rheumatol. 11: 727‑728, 1984.
47. Khan MA, van der Linden SM, Kushner I, Valkenburg HA, Cats A: Spondylitic disease without radiological evidence of sacroiliitis in relatives of HLA‑B27 positive patients. Arthritis Rheum 28: 40‑43, 1985.
48. Khan MK, Khan MA: Selection of optimal dose. Computers & Biomedical Research 18: 193‑203, 1985.
49. Khan MA: Diclofenac in the treatment of ankylosing spondylitis: Review of worldwide clinical experience and report of a double‑blind comparison with indomethacin. Semin Arthritis Rheum 15(Supplement 1): 80‑84, 1985.
50. Ballou SP, Khan MA, Kushner I: Intravenous pulse methylprednisolone followed by alternate‑day corticosteroid therapy in lupus erythematosus: A prospective evaluation. J Rheumatol 12: 944‑948, 1985.
51. de Vries RRP, Nijenhuis LE, Khan MA, Mehra NK: Paradoxical inheritance of HLA‑linked susceptibility to rheumatoid arthritis. Tissue Antigens 26: 286‑292, 1985.
52. van der Linden S, Khan MA: Iliosakralarthritis und spondylitis anklyosans Bechterew: Früherfassung und therapie. Therapeutische Umschau 42: 707‑710, 1985.
53. Arnett FC Jr, Khan MA, Wilkens RF: Are you missing ankylosing spondylitis? (E. Fuller, ed). Patient Care 20: 51‑78, January 30, 1986.
54. Payami H, Thomson G, Khan MA, Grennan DM, Sanders P, Dyer P, Dostal C: Genetics of rheumatoid arthritis. Tissue Antigens 27: 57‑63, 1986.
55. Khan MA, Khan MK: Analysis of genetic susceptibility to familial rheumatoid arthritis. Disease Markers 4: 77‑85, 1986.
56. Khan MA, Khan MK: HLA studies in familial and sporadic rheumatoid arthritis. Disease Markers 4: 67‑76, 1986.
57. Yamashita TS, Khan MA, Kushner I: Genetic analysis of families with multiple cases of rheumatoid arthritis. Disease Markers 4: 113‑121, 1986.
58. Shah BC, Khan MA: Review of ankylosing spondylitis. Comprehensive Therapy 13(Supplement 3): 52‑59, 1987.
59. Khan MA: A double blind comparison of dicloflenac and indomethacin in the treatment of ankylosing spondylitis. J Rheumatol 14: 118‑123, 1987.
60. Cats A, van der Linden SM , Goei The HS, Khan MA: Proposals for diagnostic criteria of ankylosing spondylitis and allied disorders. Clin Exp Rheumatol 5: 167‑171, 1987.
61. Payami H, Khan MA, Grennan DM, Sanders PA, Dyer PA, Thomson G: Analysis of genetic interrelationship among HLA‑associated diseases. Am J Hum Genet 41: 331‑349, 1987.
62. Yagan R, Radivoyevitch M, Khan MA: Double cortical line in the acetabular roof: A sign of disuse osteoporosis. Radiology 165: 171‑175, 1987.
63. van der Linden SM, Goei The HS, Khan MA, Cats A, Valkenburg HA: Roma locata, causa non finita: Parameters that need to be considered in revision of criteria for ankylosing spondylitis and seronegative polyarthritis. Clin Exp Rheumatol 5(Supplement 1): S109‑S110, 1987.
64. Khan MA, Wolfe F, Kleinheksel SM, Molta C: HLA DR4 and B27 antigens in familial and sporadic rheumatoid arthritis. Scand J Rheumatol 16: 433‑436, 1987.
65. Khan MA: Immunogenetics of ankylosing spondylitis: Clinically oriented aspects. Clin Exp Rheumatol 5(Supplement 1): S49‑S52, 1987.
66. Yagan R, Khan MA, Marmolya G: Role of abdominal CT, when available in patients' records, in the evaluation of degenerative changes of the sacroiliac joints. Spine 12: 1046‑1051, 1987.
67. Khan MK, Khan MA: Uniformly most powerful tests for non‑random segregation. Technical Reports No. DMS‑MK 12‑86. Department of Mathematical Sciences, Kent State University, Kent, Ohio.
68. Wolfe F, Kleinheksel SM, Khan MA: Familial versus sporadic rheumatoid arthritis: A comparison of the demographic and clinical characteristics of 956 patients. J Rheumatol 15: 400‑404, 1988.
69. Pazirandeh M, Ziran BH, Khandelwal BK, Reynolds TL, Khan MA: Relapsing polychondritis and spondyloarthropathies. J Rheumatol 15: 630‑632, 1988.
70. van der Linden SM, Khan MA, Rentsch H‑U, Gerber N, Cats A, Valkenburg HA, Tugwell PX: Chest pain without radiographic sacroiliitis in relatives of patients with ankylosing spondylitis. J Rheumatol 15: 836‑839, 1988.
71. Khan MA, Yamashita TS, Reynolds TL, Wolfe F, Khan MK: HLA‑DR4 genotype frequency and gender effect in familial rheumatoid arthritis. Tissue Antigens 31: 254‑258, 1988.
72. Khan MA: Genetics of HLA‑B27. Br J Rheumatol 27(Supplement II): 6‑11, 1988.
73. Wolfe F, Kleinheksel SM, Khan MA: Prevalence of familial occurrence in patients with rheumatoid arthritis. Br J Rheumatol 27(Supplement II): 150‑152, 1988.
74. Stastny P, Ball EJ, Khan MA, Olsen NJ, Pincus T, Gao X: HLA‑DR4 and other genetic markers in rheumatoid arthritis. Br J Rheumatol 27(Supplement II): 132‑138, 1988.
75. Khan MA, Arnett FC Jr., Moskowitz RW: HLA‑B27: Is it really of diagnostic help? Articulations 5(No. 1): 3‑6, 1988.
76. Khan MA: Ankylosing spondylitis and heterogeneity of HLA‑B27. Semin Arthritis Rheum 18: 134‑141, 1988.
77. Gao X, Ball EJ, Dombrausky L, Olsen NJ, Pincus T, Khan MA, Wolfe F, Stastny P: Class II human leukocyte antigen genes and T cell receptor polymorphisms in patients with rheumatoid arthritis. Am J Med 85(Supplement 6A):14‑16, 1988.
78. Schwartz BD, Arnett FC, Khan MA, Nepom GT, Shulman LE. Suggestions for future research directions resulting from this workshop. Am J Med 85(Supplement 6A):61, 1988.
79. Mackiewicz A, Khan MA, Reynolds TL, van der Linden S, Kushner I: Serum IgA and acute phase proteins in ankylosing spondylitis. Ann Rheum Dis 48: 99‑103, 1989.
80. Khan MA, Abdul‑Karim A: Interaction between HLA antigens and bacteria. Rev Mex Reumat 4(Supplement 1): 14‑16, 1989.
81. Khan MA, Abdul‑Karim A: Diagnosis of ankylosing spondylitis. Rev Mex Reumat 4(Supplement 1): 26‑28, 1989.
82. Molta CT, Khan MA, Aponte JC, Reynolds TL, Macintyre SS: Familial occurrence of systemic sclerosis, rheumatoid arthritis and other immunological disorders: Report of two kindreds with study of HLA antigens and review of the literature. Clin Exp Rheumatol 7: 229‑236, 1989.
83. Khan MA: Editorial Comment: HLA‑B27 testing in ankylosing spondylitis: An analysis of the pretesting assumptions. J Rheumatol 16: 634‑636, 1989.
84. Zanetakis E, Khan MA, Yagan R, Kushner I: Ochronotic arthropathy, spinal pseudoarthrosis and HLA‑B27. J Orthopedic Rheumatol 2: 48‑53, 1989.
85. Robinson WP, van der Linden SM, Khan MA, Rentsch H‑U, Cats A, Russell AS, Thomson G: HLA‑Bw60 increases susceptibility to ankylosing spondylitis in HLA‑B27 positive individuals. Arthritis Rheum 32: 1135‑1141, 1989.
86. Whitman GJ, Khan MA: Unusual occurrence of ankylosing spondylitis and multiple sclerosis in a black patient. Cleve Clin J Med 56: 819‑822, 1989.
87. Khan MA: A brief review of the HLA system. JPMA 39: 187‑191, 1989.
88. Arnett FC, Khan MA, Willkens RF: A new look at ankylosing spondylitis. Patient Care 23: 82‑101, 1989.
89. Khan MA, Yue CC: Molecular basis for the HLA association of rheumatic diseases. Autoimmunity Forum Rheumatol 1(No. 3): 2‑4, 1989.
90. Khan MA: Newer clinical and radiographic manifestations of the seronegative spondyloarthropathies. Curr Opin Rheumatol 1: 139‑143, 1989.
91. Khan MA, van der Linden SM: A wider spectrum of spondyloarthropathies. Semin Arthritis Rheum 20: 107‑113, 1990.
92. Khan MA, van der Linden SM: Ankylosing spondylitis and associated diseases. Rheum Dis Clin N Am 16: 551‑579, 1990.
93. Khan MA, van der Linden SM: Ankylosing spondylitis: Clinical aspects. Spine: State of the Art Reviews 4: 529‑551, 1990.
94. Yagan R, Khan MA: Confusion of roentgenographic differential diagnosis of ankylosing hyperostosis (Forestier's disease) and ankylosing spondylitis. Spine: State of the Art Reviews 4:561‑575, 1990.
95. Khan MA: An overview of the HLA system. Spine: State of the Art Reviews 4:595‑605, 1990.
96. Khan MA, Khan MK: HLA‑B27 as an aid to diagnosis of ankylosing spondylitis. Spine: State of the Art Reviews 4: 617‑625, 1990.
97. Khan, MA, van der Linden SM: Undifferentiated spondyloarthropathies. Spine: State of the Art Reviews 4: 657‑664, 1990.
98. Turakhia AK, Khan MA: Splinter hemorrhage as a clinical manifestation of cholesterol embolization. J Rheumatol 17: 1083‑1086, 1990.
99. Khan MA: Medical and surgical treatment of spondyloarthropathies. Curr Opin Rheumatol 2:592‑599, 1990.
100. Khan MA: Early diagnosis of ankylosing spondylitis. Revista Medica del Hospital General 53:119‑123, 1990.
101. Reynolds TL, Khan MA, van der Linden S, Cleveland RP: Differences in HLA‑B27 positive and negative patients with ankylosing spondylitis: Study of clinical disease activity and levels of serum IgA, C‑reactive protein, and haptoglobin. Ann Rheum Dis 50: 154‑157, 1991.
102. Rigby AS, Silman AJ, Voelm L, Gregory JC, Ollier WER, Khan MA, Nepom GT, Thomson G: Investigating the HLA components in rheumatoid arthritis: An additive (dominant) mode of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 8: 153‑175, 1991.
103. Khan MA: An overview of clinical spectrum and heterogeneity of spondyloarthropathies. Rheum Dis Clin N Am 18: 1‑10, 1992.
104. Zeidler H, Mau W, Khan MA: Unidifferentiated spondyloarthropathies. Rheum Dis Clin N Am 18: 187‑202, 1992.
105. Olafsson S, Khan MA: Musculoskeletal features of acne, hidradenitis suppurativa and dissecting cellulitis of the scalp. Rheum Dis Clin N Am 18: 215‑224, 1992.
106. Khan MA, Kellner H: Immunogenetics of spondyloarthropathies. Rheum Dis Clin N Am 18:837‑864, 1992.
107. Sun JP, Khan MA, Farhat AZ, Bahler RC: Alterations in cardiac diastolic function in patients with ankylosing spondylitis. Intl J Cardiol 37: 65‑72, 1992.
108. Khan MA: HLA‑B27 and pathogenesis of ankylosing spondylitis. Reumatizam (Supplement) 99‑103, 1992.
109. Khan MA: Spondyloarthropathies: editorial overview. Curr Opin Rheumatol 5: 405-407, 1993.
110. Khan MA, Lai J‑H, Chou C‑T, Chang D‑M, Liu H‑C: Spinal fractures in ankylosing spondylitis. J Musculoskeletal Med 10: 45‑57, 1993.
111. Khan MA: Etiopathogenesis of ankylosing spondylitis. Rheumatol Rev 2: 67-71, 1993.
112. Khan MA: Risk factors for rheumatic diseases. Revista Espinola de Rheumatologia 20(Supplement 1): 57-58, 1993.
113. Khan MA: Genetics. Revista Espinola de Rheumatologia 20(Supplement 1): 170-171, 1993.
114. Khan MA: Influence of genetic factors on the heterogeneity of the spectrum of spondyloarthropathies. Revista Espinola de Rheumatologia 20(Supplement 1): 271, 1993.
115. Khan MA: Pathogenesis of ankylosing spondylitis: recent advances. (Editorial). J Rheumatol 20:1273-1277, 1993.
116. Toivanen A, Khan MA: Therapeutic dilemmas in ankylosing spondylitis and related spondyloarthropathies. Rheumatol Rev 3: 21-27, 1994.
117. Kahn M‑F, Khan MA: SAPHO Syndrome. Balliere's Clinical Rheumatology 8:333-362, 1994.
118. Khan MA: Spondyloarthropathies: editorial overview. Curr Opin Rheumatol 6:351-353, 1994.
119. Mackiewicz A, Khan MA, Gorny A, Kapcinska M, Calabrese LH, Espinoza LR: Glycoforms of α1-acid glycoprotein in sera of human immunodeficiency virus infected individuals. J Infect Dis 169:1360-1363, 1994.
120. McDermott M, Kastner DL, Holloman J, Schmidt-Wolf G, Lundberg A, Sinha A, Amos C, Khan MA, Wolfe F, Rubin L, Mulcahy B, Cashin P, Molloy MGM, Clegg R, Ward R, McDevitt HO. The Role of T-Cell Receptor β Chain Genes in the Susceptibility to Rheumatoid Arthritis. Annals of the New York Academy of Sciences, 1995; 756: 173–5. doi: 10.1111/j.1749-6632.1995.tb44502.x
121. McDermott M, Kastner DL, ..., Khan MA, et al: The role of T cell receptor ß chain genes in susceptibility to rheumatoid arthritis. Arthritis Rheum 1995; 38:91-5.
122. Amor B, Dougados M, Khan MA: Management of refractory ankylosing spondylitis and related spondylarthropathies. Rheum Dis Clin N Am 1995; 21:117-28.
123. Khan MA: HLA-B27 and its subtypes in world populations. Curr Opin Rheumatol 1995; 7:263-9.
124. Khan MA: Arthritis and autoimmunity: Report on the 15th Sigrid Juselius Symposium. Rheumatol Int 1995; 15:39-42.
125. Feltkamp TE, Khan MA, Lopez de Castro JA. The pathogenic role of HLA-B27. Immunology Today 1996; 17:5-7.
126. Khan MA: Epidemiology of HLA-B27 and arthritis. Clin Rheumatol 1996; 15(suppl.1):10-12.
127. Mustafa K, Khan MA: Recognising and managing reactive arthritis. J Musculoskeletal Med 1996; 13(#6):28-41.
128. Khan MA: Editorial review: Spondyloarthropathies / spondyloarthritides. Curr Opin Rheumatol 1996; 8:267-8.
129. Ahmed Q, Chung-Park M, Mustafa K, Khan MA. Psoriatic spondyloarthropathy with secondary amyloidosis. J Rheumatol 1996; 23:1107-10.
130. McDermott E, Khan MA, ARC UK National Repository, Deighton C. Further evidence for genetic anticipation in familial rheumatoid arthritis. Ann Rheum Dis 1996; 55: 475-7.
131. Khan MA: Spondyloarthropathies: Editorial review. Curr Opin Rheumatol 1997; 9:281-3.
132. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. J Rheumatol 1997; 24: 2225-9.
133. Khan MA: Slow-acting anti-rheumatic drugs in severe ankylosing spondylitis [Editorial]. J Clin Rheumatol 1998; 4(3): 109-11.
134. Khan MA: Spondyloarthropathies: Editorial overview. Curr Opin Rheumatol 1998; 10: 279-81.
135. Walsh B, Yocum D, Khan MA: Arthritis and HLA-B27 in North American tribes. Curr Opin Rheumatol 1998; 10: 319-25.
136. Dougados M, Revel M, Khan MA: Spondylarthropathy treatment: Progress in medical treatment, physical therapy and rehabilitation. Balliere's Clinical Rheumatology 1998; 12: 717-36.
137. Espinoza L, Khan MA: Recognizing the spondyloarthropathies. Patient Care 1999; 33(#7):183-4.
138. Khan MA: A current perspective on ankylosing spondylitis and related spondyloarthropathies. JIRA 1999; 7:16-22.
139. Khan MA: Disease assessment in ankylosing spondylitis JIRA 1999; 7:52-4.
140. Khan MA: Management of ankylosing spondylitis and related spondyloarthropathies. JIRA 1999; 7:87-92.
141. van der Heijde DMFM, van der Linden SM, Bellamy N, Calin A, Dougados M, Khan MA. Which domains should be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV. J Rheumatol 1999; 26:945-7.
142. van der Heijde DMFM, Calin A, Dougados M, Khan MA, van der Linden SM, Bellamy N, on behalf of the ASAS working group. Selection of specific instuments for each domain in core set for DC-ART, SM-ARD, physical therapy, and clinical record keeping in ankylosing spondylitis: Progress report of ASAS working group. J Rheumatol 1999; 26:951-4.
143. Khan MA: Spondyloarthropathies: Editorial overview. Curr Opin Rheumatol 1999; 11:233-4.
144. McGonagle D, Khan MA, Marzo-Ortega H, O’Connor P, Gibbon W, Emery P: Enthesitis in ankylosing spondylitis and related spondyloarthropathies. Curr Opin Rheumatol1999; 11: 244-50.
145. Yunus MB, Khan MA, Rawling KK, Green JR, Shah S. A genetic study of multicase families with fibromyalgia syndrome by HLA linkage analysis. J Rheumatol 1999; 26: 408-12.
146. Khan MA: Patient-doctor. Ann Intern Med 2000, 133: 233-5.
147. Khan MA: HLA-B27 polymorphism and association with disease [Editorial]. J Rheumatol 2000; 27: 1110-4.
148. Braun J, Khan MA, Sieper J. Entheses and enthesopathy: What is the target of the immune response? Ann Rheum Dis 2000, 59: 985-994.
149. Khan MA: Update: the twenty subtypes of HLA-B27. Curr Opin Rheumatol 2000, 12: 235-238.
150. Feldtkeller E, Bruckel J, Khan MA. Scientific contributions of the ankylosing spondylitis patient advocacy groups. Curr Opin Rheumatol 2000, 12: 239-247.
151. Mijiyawa M, Oniankitan O, Khan MA. Spondyloarthropathies in sub-Saharan Africa. Curr Opin Rheumatol 2000, 12:281-286.
152. Khan MA: My self-portrait. Clin Rheumatol 2001, 20:1-2.
153. François RJ, Braun J, Khan MA: Entheses and enthesitis: a histopathological review and relevance to spondyloarthropathies. Curr Opin Rheumatol 2001, 13:255-264.
154. Reveille JD, Ball EJ, Khan MA: HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol 2001, 13:265-272.
155. Ball EJ, Khan MA: HLA-B27 polymorphism. Bone Joint Spine 2001, 68:378-382.
156. Granfors K, Märker-Hermann E, De Keyser P, Khan MA, Veys EM, Yu DT. The cutting edge of spondyloarthropathy research in the millennium. Arthritis Rheum 2002, 46:606-613.
157. Khan MA. Update on spondyloarthropathies. Ann Intern Med 2002, 136:896-907.
158. Khan MA, Ball EJ: Genetic aspects of ankylosing spondylitis. Best Pract Res Clin Rheumatol 2002; 16:675-690.
159. Khan MA. HLA-B27 and spondyloarthropathies [Editorial]. Revista Espanola de Rheumatologia 28:405-407, 2002.
160. Khan MA. Introductory comments. New treatment strategies in ankylosing spondylitis. Ann Rheum Dis 2002; 61 (Suppl 3): iii3-7.
161. Braun J, van der Heijde D, Dougados M, Emery P, Khan MA, Sieper J, van der Linden S. Staging of patients with ankylosing spondylitis: A preliminary proposal. Ann Rheum Dis 2002; 61 (Suppl 3): iii19-23.
162. Dougados M, Dijkmanns B, Khan MA, Maksymowych W, van der Linden S, Brandt J. Conventional treatments for ankylosing spondylitis. Ann Rheum Dis 2002; 61 (Suppl 3): iii40-50.
163. Khan MA. Ankylosing Spondylitis – The history of medical therapies. Clin Exp Rheumatol 2002; 20(Suppl 28): S3-S5.
164. Khan MA. Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases. Clin Exp Rheumatol 2002; 20(Suppl 28): S6-S10.
165. Feldtkeller E, Khan MA, van der Linden S, van der Heijde D, Braun J: Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003; 23:61-66.
166. Pham T, van der Heijde D, Calin A, Khan MA, van der Linden S, Bellamy N, Dougados M. Initiation of biologics in ankylosing spondylitis patients: Results of a Delphi technique within the ASAS group. Ann Rheum Dis 2003; 62: 812- 816.
167. Rudwaleit M, van der Heijde D, Khan MA, Braun J, Sieper J. How to diagnose axial spondyloarthropathy early? Ann Rheum Dis 2004; 63:535-43.
168. Zhang G, Luo J, Bruckel J, Weisman M, Schumacher HR, Khan MA, et al. Genetic Studies in Familial Ankylosing Spondylitis Susceptibility Arthritis Rheum 2004; 50:2246-2254.
169. Jin L , Weisman M, Zhang, G, Ward, M, Akey, JM, Bruckel J, Inman R, Luo J, Khan MA, et al. Lack of Linkage of IL1RN Genotype with Ankylosing Spondylitis Susceptibility. Arthritis Rheum 2004; 50:3047-3048
170. Jin L , Weisman M, Zhang, G, Ward, M, Luo J, Bruckel J, Inman R, Khan MA, et al. Lack of Association of MMP3 with Ankylosing Spondylitis Susceptibility and Severity. Rheumatol 2005; 44:55-60.
171. Martin TM, Zhang G, Luo J, Jin L, Doyle TM, Rajska BM, ----- Khan MA, -----, Rosenbaum JT, Reveille J. A locus on chromosome 9p predisposes to a specific disease manifestation, acute anterior uveitis, in ankylosing spondylitis, a genetically complex, multisystem, inflammatory disease. Arthritis Rheum 2005; 52:269-274.
172. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum. 2005; 52:1000-1008.
173. Khan MA. The perspective of two paintings by a patient-physician. Journal of Medicine and the Person. 2005; 3(No:2): 83-84.
174. Akkoc N, Khan MA. Etiopathogenic role of HLA-B27 alleles in ankylosing spondylitis. APLAR J Rheumatol 2005; 8: 146-153.
175. Zochling J, van der Heijde D, Burgos-Vargas R, Collantes E, Davis J, Dijkmans B, Dougados M, Géher P, Inman R, Khan MA, et al. ASAS / EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2006; 65:442-452.
176. Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis.
Best Pract Res Clin Rheumatol. 2006 June; 20(3):401-17.
177. Akkoc N, van der Linden S, Khan MA. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy. Best Pract Res Clin Rheumatol. 2006 June; 20(3):539-57.
178. Elyan M, Khan MA. The role of non-steroidal anti-inflammatory medications and exercise in the treatment of ankylosing spondylitis. Curr Rheumatol Report 2006; 8: 255-259.
179. Khan MA, Akkoc N. Commentary: Ten key recommendations for the management of ankylosing spondylitis. Nature Clin Pract Rheumatol 2006; 2(9):468-9.
180. Khan MA. Ankylosing spondylitis: A dual perspective of the current issues and challenges. J Rheumatol Suppl 2006; Sep;78:1-3.
181. Elyan M, Khan MA. Diagnosing ankylosing spondylitis. J Rheumatol Suppl 2006; Sep;78:12-23.
182. Khan MA, Mathieu A, Sorrentino R, Akkoc N. The pathogenic role of HLA-B27 and its subtypes in ankylosing spondylitis. Autoimmunity Reviews 2007; 6(3):183-9.
183. Khan MA, Clegg DO, Deodhar AA, et al. Meeting Report. 2006 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol 2007; 34(5):1118-1124.
184. Weber U, Pfirrmann CWA, Khan MA. Ankylosing spondylitis: update on imaging and therapy. Intl J Adv Rheumatol. 2007; 5: 2-7.
185. Gladman DD, Inman RD, Cook RR, -- Khan MA, -- Maksymowych WP. International Spondyloarthritis Inter-observer Reliability Exercise – The INSPIRE Study: I. Assessment of Spinal Measures. J Rheumatol 2007; 4(8):1733-9.
186. Gladman DD, Inman RD, Cook RR, -- Khan MA, -- van der Heijde, D. International Spondyloarthritis Inter-observer Reliability Exercise – The INSPIRE Study: II. Assessment of peripheral joints, enthesitis and dactylitis. J Rheumatol 2007; 34(8):1740-5
187. Elyan M, Khan MA. Clinical trials report: Is low-dose Infliximab every 8 Weeks Effective in treating ankylosing spondylitis? Curr Rheumatol Report 2007; 9(5):351-2.
188. Elyan M, Khan MA. Clinical trials report: Another look at low-dose Infliximab in treating ankylosing spondylitis. Curr Rheumatol Report 2007; 9(5):352.
189. Elyan M, Khan MA. Clinical trials report: Sulfasalazine in undifferentiated spondyloarthropathies. Curr Rheumatol Report 2007; 9(5):349-50.
190. Olivieri I, D’Angelo S, Cutro MS, Padula A, Peruz G, Montaruli M, Scarano E, Giasi V, Palazzi P, Khan MA. Diffuse Idiopathic Skeletal Hyperostosis may give the typical postural abnormalities of advanced ankylosing spondylitis. Rheumatology (Oxford). 2007; 46(11):1709-11.
191. Elyan M, Khan MA. Update on spondyloarthritis. J Musculoskeletal Med 2008; January, p. 31-40.
192. Khan MA. HLA-B27 and its pathogenic role. J Clin Rheumatol 2008; 14(1):50-2.
193. Elyan M, Khan MA. Spondyloarthropathies: Update on Diagnosis and Therapy. Consultant 2008; August, p. 681-91.
194. Onen, F, Akar S, Birlik M, Sari I, Gurler O, Ergor Alp, Manisali M, Khan MA, Akkoc N. Prevalence of ankylosing spondylitis and related spondyloarthritis in an urban area of Izmir, Turkey. J Rheumatol. 2008; 35(2):305-9.
195. Elyan M, Khan MA. Does physical therapy have a place in the treatment of ankylosing spondylitis. Curr Opin Rheumatol. 2008; 20(3):282-6.
196. Colbert RA, Deodhar AA, Khan MA, et al. 2007 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN). J Rheumatol. 2008; 35:1398-02.
197. Weber U, Pfirrmann CWA, Kissling RO, MacKenzie CR, Khan MA. Early spondyloarthritis in HLA-B27 positive monozygotic twin pair: A highly concordant onset, sites of involvement, and disease course. J Rheumatol. 2008; 35(7):1464-7.
198. James N, Elyan M, Khan MA. Clinical trials report: Is continuous treatment with infliximab superior to treatment upon symptom relapse in ankylosing spondylitis? Curr Rheumatol Report. 2008; 10:347-8.
199. Khan MA. Recent advances in the genetics of ankylosing spondylitis. Future Rheumatol. 2008; 3(5): 403-5.
200. Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, ...., Khan MA, ...., Sieper J. The development of Assessment in SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (Part I): Classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009; 68(6):770-6.
201. Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, …., Khan MA, …., Sieper J. The development of Assessment in SpondyloArthritis International Society (ASAS) classification criteria for axial spondyloarthritis (Part II): Validation and final selection. Ann Rheum Dis. 2009; 68(6):777-83.
202. Sieper J , van der Heijde D, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, …., Rudwaleit M. New criteria for inflammatory back pain in patients with chronic back pain – a real patient exercise of the Assessment in SpondyloArthritis International Society (ASAS). Ann Rheum Dis. 2009 68(6):784-8.
203. Weber U, Maksymowych WP, Jurik AG, Pfirrmann CWA, Rufibach K, Kissling RO, Khan MA, Lambert RGW,Hodler J. Validation of whole body against conventional magnetic resonance imaging for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondylarthritis. Arthritis Rheum (Arthritis Care Res) 2009; 61(7): 893-9.
204. Colbert RA, Deodhar AA, Fox D, Gravallese EM, Khan MA, et al. Entheses and Bones in Spondyloarthritis: 2008 Annual Research and Education Meeting of the Spondyloarthritis Research and Therapy Network (SPARTAN), J Rheumatol.2009; 36(7):1527-31.
205. Olivieri I, D’Angelo S, Palazzi P, Padula A, Mader R, Khan MA. Diffuse Idiopathic Skeletal Hyperostosis: A Condition That Needs to Be Differentiated from Spondyloarthritis. Curr Rheumatol Report. 2009; Oct; 11(5): 321-8.
206. Magrey M, Khan MA. New insights into SAPHO syndrome. Curr Rheumatol Report. 2009; Oct; 11(5):329-33.
207. Weber U, Hodler J, Jurik AG, Pfirrmann CWA, Rufibach K, , Kissling RO, Khan MA, Lambert RGW, Maksymowych WP. Assessment of active spinal inflammatory changes in patients with axial spondyloarthritis: Validation of whole body MRI against conventional MRI. Ann Rheum Dis. 2010; 59: 648-53.
208. Lipps J, Khan MA. Vogt-Koyanagi-Harada syndrome: A rheumatologic perspective. Int. J Clin Rheumatol. 2010; 5(2): 255-63.
209. Magrey M, Khan MA. HLA-B27 homozygosity and clinical features of ankylosing spondylitis. Curr Rheumatol Report. 2010; 12: 309-10
210. Magrey M, Khan MA. Osteoporosis in ankylosing spondylitis. Curr Rheumatol Report. 2010; 12: 332-6
211. Khan MA. Remarkable Polymorphism of HLA-B27: An Ongoing Saga. Curr Rheumatol Report. 2010; 12: 337-41.
212. Alabed IE, Qushmaq KA, Khan MA. Psoriasis induced by infliximab in a Saudi patient with ankylosing spondylitis. Saudi Med J 2010; Sep;31(9):1054-6.
213. Ozgocmen S, Akgul O, Khan MA. Mnemonic for assessment of the spondyloarthritis international society criteria. J Rheumatol. 2010 Sep;37(9):1978.
214. Antonelli M, Bupathi M, Janakiram M, Khan MA. Acquired erythrocytosis on treatment with infliximab for ankylosing spondylitis. J Rheumatol. 2011 Mar 38(3):581-3
215. Khan MA. Ankylosing spondylitis and related spondyloarthropathies: the dramatic advances in the past decade. Rheumatology 2011; 50: 637-9.
216. Braun J, van den Berg R, Baraliakos X, …., Khan MA, ...., van der Heijde D. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (AS). Ann Rheum Dis. 2011; June: 70(6):896-904.
217. Khan MA, Garcia-Kutzbach A, Espinoza LR. Treatment of ankylosing spondylitis: A critical reappraisal of nonsteroidal antiinflammatory drugs and corticosteroids. Am J Med Sciences. 2012 May; 343(5):350-2.
218. Mustafa KN, Hammoudeh M, Khan MA. HLA-B27 prevalence in Arab populations and among patients with ankylosing spondylitis. J Rheumatol. 2012, Aug: 39(8):1675-7.
219. Ozgocmen S, Khan MA. Current concept of spondyloarthritis: Special emphasis on early referral and diagnosis. Curr Rheumatol Report. 2012, Oct; 14(5):409-14. Erratum: 2012 Dec; 14(6):624.
220. Magrey M, Antonelli M, James N, Khan MA. High frequency of fibromyalgia in patients with psoriatic spondylitis: A pilot study. Arthritis 2013, Published online February 14. 4 pages Article ID 762921
221. Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I, et al. The fibromyalgia family study: A genome-scan linkage study. Arthritis Rheum. 2013; April: 65(4): 1122-8.
222. Lim D, James N, Sobia H, Khan MA. Arthritis associated with acne conglobata, hidradenitis suppurativa and dissecting cellulitis of the scalp: A review with illustrative cases. Curr Rheumatol Report. 2013, Aug; 15(8):346. doi: 10.1007/s11926-013-0346-y.
223. Khan MA. Polymorphism of HLA-B27: 105 subtypes currently known. Curr Rheumatol Report. 2013. October (15)10:362. doi 10.1007/s11926-013-0362-y
224. Bao C, Huang F, Khan MA, et al. Safety and efficacy of golimumab in Chinese patients with active ankylosing spondylitis: 1-year results of a multicentre, randomized, double-blind, 5 placebo-controlled phase III trial. Rheumatology 2014; 53:1654-83.
225. Magrey M, Khan MA. Gene-gene interactions of HLA-B27 and ERAP1 in ankylosing spondylitis: Finding the pieces of the puzzle. Int. J Clin Rheumatol. 2014; 9(6):539-42.
226. Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a health index in patients with ankylosing spondylitis (ASAS HI): Final result of a global initiative based on the ICF guided by ASAS. Ann Rheum Dis. 2015; 74(5):830-5.
227. Akkoc N, Khan MA: Looking into the new ASAS Classification Criteria for axial spondyloarthritis through the other side of the glass. Curr Rheumatol Rep.. 2015;17(6):515. doi: 10.1007/s11926-015-0515-2.
228. Antonelli M, Khan MA, Magrey M. Differential adverse events between TNF-α inhibitors and IL-17 axis inhibitors for the treatment of spondyloarthritis. Curr Treatment Options in Rheumatol. 2015; Jun;1(2): 239-54. doi: 10.1007/s40674-015-0022-7.
229. van der Linden S, Akkoc N, Brown MA, Robinson PC, Khan MA. The ASAS criteria for axial spondyloarthritis: strengths, weaknesses and proposals for a way forward. Curr Rheumatol Report. 2015;17(9):535. doi: 10.1007/s11926-015-0535-y
230. Khan MA, Haroon M, Rosenbaum JT. Acute Anterior Uveitis and Spondyloarthritis: More Than Meets The Eye. Curr Rheumatol Rep. 2015;17(9): 536. doi: 10.1007/s11926-015-0536-x
231. Akkoc N, Khan MA: ASAS Classification Criteria for axial spondyloarthritis: time to modify. Clin Rheumatol 2016;35(6):1415-23.
232. Khan MA. Accomplishments of Heinz Baumberger PhD: a remarkable patients with ankylosing spondylitis for 72 years. Clin Rheumatol 2016;35(6):1637-41.
233. Magrey M, Lewis S, Khan MA. Utility of DXA scanning and risk factors for osteoporosis in ankylosing spondylitis -- A prospective study. Semin Arthritis Rheum 2016;46:88-94.
234. Kiltz U, van der Heijde D, Boonen A, Bautista-Molano W, Burgos-Vargas R, Chiowchanwisawakit P, Duruoz T, El-Zorkany B, Essers I, Gaydukova I, Géher P, Gossec L, Grazio S, Gu J, Khan MA et al. Measuring impairments of functioning and health in patients with axial spondyloarthritis by using the ASAS Health Index and the Environmental Item Set: translation and cross-cultural adaptation into 15 languages. RMD Open. 2016 Oct 4;2(2):e000311
235. van der Linden S, Khan MA. Can we currently and confidently assess the true burden of illness due to nonradiographic axial spondyloarthritis? (Editorial). Clin Exp Rheumatol. 2016 Nov-Dec;34(6):963-965. Epub 2016 Nov 28.
236. Khan MA. An Update on the Genetic Polymorphism of HLA-B*27 with 213 Alleles Encompassing 160 Subtypes (and Still Counting). Curr Rheumatol Rep. 2017 Feb;19(2):9. doi: 10.1007/s11926-017-0640-1.
237. Magrey M, Khan MA. The paradox of bone formation and bone loss in ankylosing spondylitis: Evolving new concepts of bone formation and future trends in management. Curr Rheumatol Rep. 2017 Apr;19(4):17. doi: 10.1007/s11926-017-0644-x.
238. Akkoc N, Yarkan H, Kenar G, Khan MA. Ankylosing Spondylitis: HLA-B*27 Positive versus HLA-B*27 Negative Disease. Curr Rheumatol Rep. 2017 May;19(5):26. doi: 10.1007/s11926-017-0654-8.
239. Bilal J, Riaz IB, Kamal MU, Elyan M, Sudano D, Khan MA. Systematic Review and Meta-Analysis of Efficacy and Safety of Novel Interleukin Inhibitors in the Management of Psoriatic Arthritis. J Clin Rheumatol. 2018 January;24:6-13.
240. Khan MA, van der Linden S. Axial Spondyloarthritis: A Better Name For An Old Disease. A Step Toward Uniform Reporting, ACR Open Rheumatology (ACROR). 2019. DOI:10.1002/acr2.11044
241. Ward MM, Deodhar A, Gensler LS, Dubreuil N. Yu D, Khan MA, et al. 2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis. Arthritis Rheumatol. 2019 Oct;71(10):1599-1613. doi: 10.1002/art.41042. Epub 2019 Aug 22.
242. Baumberger H, Giovanni ME, Khan MA. Description of «Panoramic Field» for Assessment of Impaired Ability of Ankylosing Spondylitis Patients to Fully See Their Surroundings Despite Having Normal Field of Vision. Rheuma Schweiz Fachzeitschrift. 6:2019, 30-34.
243. Ji X, Hu L, Wang Y, Lou Y, Zhu J, Zhang J, Khan MA, Huang F. “Mobile Health” for the management of spondyloarthritis, and its application in China. Curr Rheumatol Rep. 21 (11), 61. 2019, November 19. . https://doi.org/10.1007/s11926-019-0860-7
244. Chetrit M, Kapadia S. Khan MA. State of the art management of aortic valve disease in ankylosing spondylitis. Curr Rheumatol Rep. DOI: 10.1007/s11926-020-00898-4
245. Akkoc N, Khan MA. Is axial spondyloarthritis more common than rheumatoid arthritis? Curr Rheumatol Rep. 22, 54 (2020). https://doi.org/10.1007/s11926-020-00934-3
246. Magrey M, Charles T, Khan MA. Relationship between disease activity measures, functional status, and fibromyalgia symptom scale in ankylosing spondylitis: a cross-sectional study. J Clin Rheumatol. July 22, 2020. doi: 10.1097/RHU.0000000000001490.
247. Mader R, ….. Khan MA. Diffuse Idiopathic Skeletal Hyperostosis …… Curr Rheumatol Rep. (in press))
248. Robinson PC, van der Linden S, Khan MA, Taylor WJ. Axial Spondyloarthritis: Concept, construct, classification and implications for therapy. (Submitted for publication). reference number: NRR-19-187V1B).
LETTERS TO EDITOR:
1. Khan MA, Kushner I, Braun WE: Low incidence of HLA‑B27 in American Blacks with spondyloarthropathies. Lancet 1976; i: 483.
2. Khan MA, Ricanati ES, Chung‑Park MJ: Lupus nephritis and renal vein thrombosis. Ann Intern Med. 1977; 86: 114.
3. Khan MA, Kushner I, Braun WE, Schacter BZ, Steinberg AG: HLA‑B7 and ankylosing spondylitis in American Blacks. N Engl J Med 1977; 297: 513.
4. Khan MA: Ankylosing spondylitis and HLA‑B27 in Punjabis. Lancet 1977; ii: 504.
5. Khan MA, Ganuza C: Ruptured popliteal cyst and thrombophlebitis. Arthritis Rheum 1977; 20: 1561‑2.
6. Braun WE, Dejelo CL, Clough JF, Beck KA, Schacter BZ, Khan MA: No association of known DR antigens with ankylosing spondylitis. N Engl J Med 1978; 298: 744‑5.
7. Khan MA, Kushner I, Braun WE: B27‑negative HLA‑Bw16 in ankylosing spondylitis. Lancet i: 1978; 1370‑1.
8. Khan MA, Kushner I, Ballou SP, Braun WE: Familial rheumatoid arthritis and HLA‑DRw4. Lancet 1979; i: 921‑2.
9. Hammoudeh M, Khan MA, Kushner I: Unilateral rheumatoid arthritis. Arthritis Rheum 1981; 24:1218.
10. Hammoudeh M, Khan MA: Clinical variants of systemic lupus erythematosus resembling multiple sclerosis. J Rheumatol 1982; 9:336‑8.
11. Yue CC, Khan MA: HLA antigens and diffuse idiopathic hyperostosis. N Engl J Med 1983; 309: 924.
12. Khan MA: HLA antigens and acute anterior uveitis. J Rheumatol 1984; 11: 556‑7.
13. Khan MA: HLA haplotypes in multiple case families with rheumatoid arthritis. Clin Rheumatol 1984; 3: 557.
14. van der Linden SM, Khan MA: The risk of ankylosing spondyltis in HLA‑B27 positive individuals. Reply. J Rheumatol 1986; 13: 220‑2.
15. van der Linden SM, Khan MA: On the prevalence of ankylosing spondylitis. Reply. J Rheumatol 1986; 13: 222‑224.
16. Khan MA, Sun JP, Bahler RC: Echocardiographic evidence of altered cardiac diastolic function in ankylosing spondylitis. Lancet 1987; i: 1501.
17. Bluestone R, Khan MA, Ellis M, Sears MA: Ankylosing Spondylitis Association. J Rheumatol 1988; 15: 154‑5.
18. Yagan R, Khan MA, Radivoyevitch MA: Double acetabular line. Reply. Radiology 1988; 167: 873‑4.
19. Reynolds TL, Khan MA: HLA‑B27 and the putative susceptibility gene for ankylosing spondylitis J Rheumatol 1988; 15: 1037‑8.
20. Reynolds TL, Khan MA: B7 cross‑reactive antigens in spondyloarthropathies. J Rheumatol 1988; 15: 1454.
21. Iskander M, Khan MA: Candida albicans infection of a prosthetic knee replacement. J Rheumatol 1988; 15:1594‑5.
22. Iskander M, Khan MA: Chorea as the initial presentation of oral contraceptive related systemic lupus erythematosus. J Rheumatol 1989; 16: 850‑1.
23. Khan MA: HLA‑B27 and B12 (B44) in Crohn's disease patients with ankylosing spondylitis. J Rheumatol 1989; 16:851‑2.
24. Khan MA, Yagan R: Sacroiliac abnormalities in DISH. J Rheumatol 1989; 16: 1399.
25. Khan MA: Genetic predisposition to rheumatoid arthritis. N Engl J Med 1990; 323: 996.
26. van den Borne B, van Laere G, Khan MA: Tendon rupture in systemic lupus erythematosus. J Rheumatol 1990; 17: 1571.
27. Khan MA: HLA‑B27 and arthritis: Back to the future. J Rheumatol 1991; 18:1638.
28. Yagan R, Khan MA: The coexistence of ochronosis and ankylosing spondylitis. J Rheumatol 1991; 18: 1639-40.
29. Khan MA: Delay in the radiographic detection of sacroiliitis in ankylosing spondylitis. (Comments on the article by Lipsky and Taurog). Arthritis Rheum 1992; 35:727.
30. Khan MA: First International Congress on Spondyloarthropathies: Focus on Pathogenic, Clinical, and Therapeutic Aspects. Rheumatology 1998; 12(3):8-11.
31. Khan MA. Ankylosing spondylitis or ankylosing hyperostosis. BMJ vol 319; Letter to Editor (eletter), July 1999. http://bmj.bmjjournals.com/cgi/eletters/319/7203/171#3975.
32. Khan MA: Comments on the article by Sweeny et al: Total hip arthroplasty in ankylosing spondylitis. J Rheumatol 2002; 29:1342.
33. Akkoc N, Khan MA: Overestimation of the prevalence of ankylosing spondylitis in the Berlin study: Comment on the article by Braun et al. Arthritis Rheum 2005; 52(12):4048-9.
34. Akkoc N, Khan MA: ASAS classification criteria for axial spondyloarthritis: a look at the unfilled part of the glass. Clin Exp Rheumatol. 2014; 32(6). Suppl.87: S14-S15.
35. Akkoc N, Khan MA: Radiographic axial spondyloarthritis versus ankylosing spondylitis. Clin Exp Rheumatol. 2015; Aug 27 [Epud ahead of print]
36. Akkoc N, Khan MA: Treatment of Patients With Nonradiographic Axial Spondyloarthritis Who Have Negative Magnetic Resonance Imaging Results and Normal C-Reactive Protein Levels at Baseline: Comment on the Article by Ward et al. Arthritis Rheumatol 2016;Jun;68(6):1563. (and Arthritis Care Research 2016;Jun;68(6):886)
37. van der Linden S, Khan MA. Axial spondyloarthritis in relatives of probands with ankylosing spondylitis. Comments on the article by Turina et al. Arthritis Rheumatol. 2016 Dec 21. doi: 10.1002/art.40026. [Epub ahead of print]
SCIENTIFIC ABSTRACTS:
1. Khan MA, Braun WE, Kushner I: Low frequency of HLA‑B27 in American Blacks with ankylosing spondylitis. Clin Res 25: 331A, 1976.
2. Khan MA, Kushner I, Braun WE: A comparison of clinical features in HLA‑B27 positive and negative patients with ankylosing spondylitis. Arthritis Rheum 19: 804‑805, 1976.
3. Goldberg M, Khan MA, Kushner I, Powell E: Plasma dependent impaired lymphocyte responsiveness in ankylosing spondylitis. Arthritis Rheum 19: 798, 1976.
4. Khan MA, Braun WE, Kushner I, Steinberg AG: Low prevalence of HLA‑B27 in American Blacks with ankylosing spondylitis. HLA and Disease, Abstracts. Paris, Editions INSERM, p. 40, 1976.
5. Khan MA, Kushner I, Braun WE, Grecek DE, Steinberg AG: HLA‑B27 homozygosity in ankylosing spondylitis: Relationship to risk and severity. Clin Res 25: 362A, 1977.
6. Khan MA, Kushner I, Braun WE, Grecek DE, Steinberg AG: HLA‑B27 homozygosity in ankylosing spondylitis: Relationship to risk and severity. XIV International Congress of Rheumatology Abstracts. San Francisco, p.165, 1977.
7. Khan MA, Kushner I, Braun WE: Association of HLA‑B7 with ankylosing spondylitis in HLA‑B27 negative American Black patients. Clin Res 25: 582A, 1977.
8. Khan MA, Kushner I, Freehafer AA: Sacroiliac joint abnormalities in paraplegics. Fourth Annual Meeting of the Central Rheumatism Association, Abstracts, Snowmass, Colorado, January 15‑16, 1978.
9. Khan MA, Kushner I, Braun WE: Association of HLA‑B7 with ankylosing spondylitis in HLA‑B27 negative American Black patients. Fourth Annual Meeting of the Central Rheumatism Association, Abstracts, Snowmass, Colorado, January 15‑16, 1978.
10. Khan MA, Kushner I, Braun WE: A subgroup of ankylosing spondylitis associated with HLA‑B7 in American Blacks. Arthritis Rheum 21: 569‑570, 1978.
11. Khan MA, Askari AD, Braun WE, Aponte CJ: Reiter's syndrome: Diagnostic value of HLA‑B27 in Whites and Blacks and a comparison of clinical features in B27(+) and B27(‑) patients. VII Pan American Congress of Rheumatology, Abstracts, Bogota, Columbia, p. 56, 1978.
12. Khan MA, Khan MK: Decreased survival in ankylosing spondylitis: A life‑table analysis. Clin Res 26: 673A, 1978.
13. Khan MA, Khan MK, Kushner I: Evidence of decreased survival in ankylosing spondylitis by life‑table analysis. Arthritis Rheum 22: 628, 1979.
14. Campbell PB, Khan MA, Kushner I: Demonstration of a monocyte leukotactic defect in ankylosing spondylitis. Arthritis Rheum 22: 597, 1979.
15. Khan MA, Kushner I, Braun WE: Genetic heterogeneity in primary ankylosing spondylitis. Arthritis Rheum 22:628, 1979.
16. Khan MA, Kushner I, Braun WE: Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis. Clin Res 28: 141A, 1980.
17. Khan MA, Kushner I, Braun WE, Ballou SP: Clinical and HLA Studies of familial rheumatoid arthritis. Clin Res 28: 141A, 1980.
18. Khan MA, Braun WE, Steinberg AG, Kushner I, Dejelo CL, Ballou SP: HLA studies of familial rheumatoid arthritis. Clin Res 28: 29A, 1980.
19. Khan MA, Kushner I, Braun WE: Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis. Arthritis Rheum 23: 703, 1980.
20. Khan MA, Braun WE, Steinberg AG, Kushner I, Dejelo CL, Ballou SP: Clinical and HLA studies in familial rheumatoid arthritis. Arthritis Rheum 23: 702‑703, 1980.
21. Nunez G, Moore S, Ball GV, Hurd E, Khan MA, Stastny P: The inheritance of HLA haplotypes in families with adult rheumatoid arthritis. Arthritis Rheum 23: 726, 1980.
22. Khan MA, Miron SD, Patel S, Kushner I, Ballou SP, Wiesen E, Bellon E: The comparative value of standard radiography, quantitative scintigraphy and computerized tomography in sacroiliitis. Clin Res 28: 778A, 1980.
23. Khan MA, Braun WE, Steinberg AG, Kushner I, Dejelo CL, Ballou SP: HLA studies of familial rheumatoid arthritis. Abstract No. 8.5.31, 4th International Congress of Immunology, Paris, 1980.
24. Khan MA, Kushner I, Braun WE: Association of HLA‑A2 with uveitis in HLA‑B27 positive patients with ankylosing spondylitis. Abstract No. 8.5.32, 4th International Congress of Immunology, Paris, 1980.
25. Khan MA, Miron SD, Kushner I, Ballou SP, Wiesen EJ, Bellon EM: The comparative value of standard radiography, quantitative scintigraphy and computerized tomography in sacroiliitis. Arthritis Rheum 24(Supplement): S119, 1981.
26. Ballou SP, Khan MA, Kushner I: Clinical features of lupus: differences related to age of onset and race. Arthritis Rheum 24(Supplement): S120, 1981.
27. Miron SD, Khan MA, Wiesen EJ, Kushner I, Bellon EM: An improved technique for quantitative sacroiliac scintigraphy. Proceedings of the 29th Annual Meeting of the Association of University Radiologists, p. 35, 1981.
28. Khan MA, Braun WE: Acute anterior uveitis in Asian‑American patients with ankylosing spondylitis. Clin Res 30: 472A, 1982.
29. Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease: Rheumatoid arthritis. Clin Res 30: 292A, 1982.
30. Khan MA, Braun WE: Acute anterior uveitis in Reiter's syndrome: The influence of HLA‑B27 and race. Clin Res 30: 472A, 1982.
31. Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease: Rheumatoid arthritis. Arthritis Rheum 25: S136, 1982.
32. Khan MA, Braun WE: Acute anterior uveitis in Reiter's syndrome: The influence of HLA‑B27 and race. Arthritis Rheum 25: S134, 1982.
33. Khan MA, Hammoudeh M: Genetics of HLA‑associated diseases: ankylosing spondylitis and related spondyloarthropathies. Clin Res 30: 806A, 1982.
34. Ballou SP, Khan MA, Kushner I, Braun WE: HLA‑DR3 is not associated with antibodies to DNA. Clin Res 30: 803A, 1982.
35. Khan MA, Braun WE: Acute anterior uveitis in ankylosing spondylitis: The influence of HLA and race. Aust NZ J Med 12: 563, 1982.
36. Khan MA, Braun WE: Acute anterior uveitis in Reiter's syndrome: The influence of HLA‑B27 and race. Aust NZ J Med 12: 563‑564, 1982.
37. Khan MA, Hammoudeh M, Braun WE, Kushner I: Genetics of HLA‑associated diseases: Ankylosing spondylitis and related spondyloarthropathies. Aust NZ J Med 12: 564, 1982.
38. Khan MA, Jumshyd A: Ankylosing hyperostosis in American Blacks: A prospective study. Aust NZ J Med 12: 564, 1982.
39. Khan MA, Kushner I, Weitkamp LR: Genetics of HLA‑associated disease: Rheumatoid arthritis. Aust NZ J Med 12: 564‑565, 1982.
40. Khan MA, Hammoudeh M: Genetics of HLA‑associated diseases: ankylosing spondylitis and related spondyloarthropathies. Clin Res 31: 450A, 1983.
41. Raum D, Awdeh ZL, Glass D, Coblyn JS, Weinblatt M, Holdsworth D, Strong L, Rossen R, Kammer G, Khan MA, Yunis EJ, Alper CA: Extended haplotypes of chromosome six in adult rheumatoid arthritis. Clin Res 31:493A, 1983.
42. Khan MA, Hammoudeh MK: Genetics of HLA‑associated diseases: ankylosing spondylitis and related spondyloarthropathies. Arthritis Rheum 26: S18, 1983.
43. van der Linden S, Cats A, Valkenburg HA, Khan MA: Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Clin Res. 31: 734A. 1983.
44. Yamashita TS, Khan MA, Kushner I: Pedigree analysis of 24 multiple‑case families with rheumatoid arthritis. Clin Res 31: 735A, 1983.
45. Khan MA, Yamashita TS, Kushner I: Genetic linkage studies of familial rheumatoid arthritis. Clin Res 31: 784A, 1983.
46. Ballou SP, Khan MA, Kushner I: Studies of monocyte Fc receptor‑mediated phagocytic activity in ankylosing spondylitis. Clin Res 31: 801A, 1983.
47. Khan MA, Khanam H. Ankylosing spondylitis in Pakistanis: HLA and family studies. 4th International Conference, Association of Pakistani Physicians. Abstract Book; December 20-22, 1983.
48. van der Linden SJ, Cats A, Valkenburg HA, Khan MA. Evaluation of the diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Br J Rheumatol. 23:148. 1984.
49. Khan MA, Yamashita TS, Kushner I: Genetic linkage studies of familial rheumatoid arthritis. Ann Rheum Dis 43: 118, 1984.
50. Khan MA, van der Linden S, Kushner I: Symptomatic ankylosing spondylitis without radiographic sacroiliitis in B27‑positive relatives. Arthritis Rheum 27: S31, 1984.
51. Khan MA, Yamashita TS, Kushner I: Genetic analysis of 24 multiple case families with rheumatoid arthritis. Arthritis Rheum 27: S26, 1984.
52. van der Linden Sj, Valkenburg HA, Cats A, Khan MA, Kushner I: Symptomatic ankylosing spondylitis without radiographic sacroiliitis in B27‑positive relatives. Br J Rheumatol 23: 148, 1984.
53. Ballou SP, Khan MA, Kushner I, Zachary A, Braun WE: Association of systemic lupus erythematosus with HLA‑Cw7. Clin Res 32: 755A, 1984.
54. Ballou SP, Khan MA, Kushner I: Studies of monocyte phagocytic function in ankylosing spondylitis. Clin Res 32: 756A, 1984.
55. Payami H, Khan MA, Thomson G: Family and population studies of inheritance of rheumatoid arthritis. Clin Res 32: 758A, 1984.
56. Ballou SP, Khan MA, Kushner I: Prospective evaluation of intravenous pulse methylprednisolone followed by alternate‑day corticosteroid therapy in systemic lupus erythematosus. Clin Res 32: 819A, 1984.
57. Khan MA, Yamashita TS, Kushner I: The mode of inheritance of rheumatoid arthritis. Human Immunology 12: 120‑121, 1985.
58. Payami H, Khan MA, Thomson G: Family and population studies of inheritance of rheumatoid arthritis. Human Immunology 12: 121, 1985.
59. Ballou SP, Khan MA, Kushner I: Studies of monocyte phagocytic function in ankylosing spondylitis. Arthritis Rheum 28(Supplement): S50, 1985.
60. van der Linden S, Valkenburg H, Cats A, Khan MA: Are women relatively protected from developing ankylosing spondylitis? Arthritis Rheum (Supplement) 594, 1985.
61. Khan MA, Reynolds TL, Ballou SP, Kushner I: HLA haplotype distribution in familial rheumatoid arthritis. Clin Res 33: 920A, 1985.
62. Ballou SP, Khan MA, Braun WE, Kushner I: Association of the HLA‑C allele, Cw7, with systemic lupus erythematosus. Clin Res 33: 916A, 1985.
63. Khan MA, Khan MK: Evidence for an HLA‑linked susceptibility gene in rheumatoid arthritis. Clin Res 34: 618A, 1986; Arthritis Rheum 29: S103, 1986; Br J Rheumatol 25(Supplement): Abstract No. 50, 1986.
64. Wolfe F, Kleinheksel SM, Khan MA: Familial rheumatoid arthritis: Epidemiological and clinical features. PANLAR 1986 Meeting Abstract Book, p. 161 (Abstract B60), 1986.
65. Khan MA: Immunogenetics of seronegative polyarthritis. Clinically oriented aspects. EULAR Symposium Rome 1986 Meeting Abstract Book, p. 40, 1986.
66. van der Linden SJ, Rentsch HU, Gerber N, Khan MA, Cats A, Valkenburg HA: An increased prevalence of thoracic spine pain in HLA‑B27 positive relatives of patients with ankylosing spondylitis: A confirmative report. EULAR Symposium Rome 1986 Meeting Abstract Book, p. 63, 1986.
67. Wolfe F, Kleinheksel SM, Khan MA: Familial rheumatoid arthritis: Epidemiological and clinical features. Arthritis Rheum 30:(Supplement 1), S18, 1987
68. Khan MA, Wolfe F, Kleinheksel SM, Khan MK: Immunogenetic and epidemiologic studies in non‑familial and familial rheumatoid arthritis. Fed Proc 46(Supplement 3): 426, 1987.
69. Sun J‑P, Khan MA, Bhaler RC: Impairment of cardiac diastolic function in patients with ankylosing spondylitis, as evaluated by Doppler echocardiography. Br J Rheumatol 26(Supplement 1): 71, 1987.
70. Khan MA, Wolfe F, Kleinheksel SM, Khan MK: Clinical, epidemiological and immunogenetic studies of familial and non‑familial rheumatoid arthritis. Br J Rheumatol 26(Supplement 1): 43, 1987.
71. van der Linden S, Cats A, Goe The HS, Khan MA: Proposals for revision of diagnostic criteria for ankylosing spondylitis (AS). Arthritis Rheum 30(Supplement 4): S75, 1987.
72. Khan MA, Sun J‑P, Bahler RC: Impairment of cardiac diastolic function in patients with ankylosing spondylitis (AS), as evaluated by Doppler echocardiography. Arthritis Rheum 30(Supplement 4): S74, 1987.
73. Ball EJ, Dombrausky L, Hoover M, Pincus T, Olsen N, Khan MA, Capra JD, Stastny P: Rheumatoid arthritis is associated with a polymorphic restriction fragment of the human T cell receptor gene Arthritis Rheum 30 (Supplement 4): S26, 1987.
74. Yamashita TS, Khan MA, Wolfe E, Stastny P: Genetic epidemiology of familial rheumatoid arthritis (RA): Study of 70 multi‑case families. Am J Hum Genet 41(Supplement 3): A264, 1987.
75. Khan MA, Yamashita TS, Stastny P, Wolfe F, Kleinheksel S, Khan MK: Familial rheumatoid arthritis and homozygosity for HLA‑DR4. Arthritis Rheum 31(Supplement 1): R29, 1988.
76. Khan MA, Yamashita TS, Wolfe F, Kleinheksel S, Khan MK: Effect of gender and HLA‑DR4 genotype in familial rheumatoid arthritis. Arthritis Rheum 31(Supplement 1): R31, 1988.
77. Mackiewicz A, van der Linden S, Khan MA, Kushner I: Serum IgA and acute phase proteins in HLA B27(+) versus B27(‑) ankylosing spondylitis. Arthritis Rheum 31(Supplement 1): R29, 1988.
78. Mackiewicz A, van der Linden S, Reynolds TL, Khan MA, Kushner I: Positive correlation between serum levels of IgA and acute phase proteins (APP) suggests a pathogenic role of gastrointestinal (GI) inflammation in ankylosing spondylitis (AS). Arthritis Rheum 31(Supplement 4): S96, 1988.
79. Robinson WP, van der Linden S, Khan MA, Thomson G: A B27/Bw60 interaction effect for ankylosing spondylitis among Caucasians. Arthritis Rheum 31(Supplement 4): S112, 1988.
80. Shah Z, Khan MA, Green H, Rashad F: Study of articular cartilage and para‑articular soft tissue structures of shoulder joints by ultrasonography in rheumatoid arthritis patients and controls. J Ultrasound Med 7(Supplement 10): S245, 1988.
81. Reynolds TL, Khan MA, van der Linden S, Cleveland RP, Mackiewicz A: HLA‑B27 and clinical disease activity correlate with serum IgA and acute phase proteins in ankylosing spondylitis patients. Arthritis Rheum 32(Supplement): S47, April 1989.
82. Mackiewicz A, Khan MA, Calabrese L, Espinoza LF: N‑glycan microheterogeneity of α1‑acid glycoprotein in HIV infected patients with and without arthritis. Arthritis Rheum 35(Supplement):S86, September 1992.
83. Khan MA, Buniel J: Genetic studies of anti‑Ro (SS‑A) and other autoantibodies in white families with multiple cases of rheumatoid arthritis. Arthritis Rheum 35(Supplement):S285, September 1992.
84. Yunus MB, Rawlings KK, Khan MA: A study of multicase families with fibromyalgia with HLA typing. Arthritis Rheum 35(Supplement):S285, September 1992.
85. McDermott M, Kastner DL, Holloman J, Schmidt-Wolf G, Lundberg A, Sinha A, Amos C, Khan MA, Wolfe F, Rubin L, Mulcahy B, Cashin P, Molloy MGM, Clegg R, Ward R, McDevitt HO. Segregation of TCRß chain haplotypes in multiplex rheumatoid arthritis families. Presented at Keystone Symposium on Molecular and Cellular Biology. January, 1993.
86. Rubin LA, McDermott M, Kastner DL, ..., Khan MA, et al: The role of T cell receptor ß chain haplotypes in conferring genetic susceptibility to rheumatoid arthritis. Arthritis Rheum 36(Supplement):S197, September 1993.
87. Khan MA, Mustafa KN, Ayoubi N: Epidemiologic approach to inflammatory bowel disease and spondyloarthropathy. Clin Exp Rheumatol 12:99, 1994.
88. Khan MA: HLA-B27 heterogeneity. Clin Exp Rheumatol 12:105, 1994.
89. Khan MA: The impact of HLA-B27 subtype on the occurrence of spondyloarthropathies. Scand J Rheumatol Supplement 98, Abstract 235, 1994.
90. Yunus MB, Rawlings KK, Khan MA, Green JR. Genetic studies of multicase families with fibromyalgia syndrome. Arthritis Rheum 38 (Supplement):S247,1995.
91. Reveille J, Fraser P, Taurog J, Pollack M, Ahearn J, Khan MA, Appleyard J, Arnett F. HLA-B27 subtypes in African Americans with spondyloarthropathy (SpA). Arthritis Rheum 39 (Supplement):S 204,1996.
92. Yunus MB, Rawlings KK, Khan MA, Green JR. Fibromyalgia syndrome (FMS): Evidence of genetic linkage to HLA. Arthritis Rheum 39 (Supplement):S275,1996.
93. van der Heijde D, Bellamy N, Calin A, Dougados M, Khan MA, van der Linden S. Preliminary core sets for endpoints in ankylosing spondylitis. Arthritis Rheum 40 (Supplement):S62,1997.
94. Khan MA. The twenty HLA-B27 subtypes – B*2701 to B*2720. J Rheumatol 27(Supplement 59): p. 29, 2000.
95. Reveille JD, Inman R, Khan MA. et al. Family studies in ankylosing spondylitis. J Rheumatol 27 (Suppl 59):5, 2000.
96. Reveille JD, Bruckel J, Inman R, Weisman M, Khan MA. et al. Genetic studies in ankylosing spondylitis. Arthritis Rheum 43(Supplement):S2666, 2000.
97. Benjamin M, Bollow M, Braun J, ….. ,Khan MA, …., Poole AR. Anatomy and biochemistry of entheses. Ann Rheum Dis 59: 995-999, 2000.
98. Reveille JD, Bruckel J, Inman R, Weisman M, Khan MA, et al. Genetic studies in familial ankylosing spondylitis: The North American Spondylitis Consortium experience. Ann Rheum Dis 60(suppl. I): p 6, July 2001.
99. Khan MA. Update on psoriasis as it relates to spondyloarthropathies. Ann Rheum Dis 60(suppl. I): p 6, July 2001.
100. Reveille JD, Bruckel J, Inman R, ……Khan MA, ..…et al. Evidence for a second major histocampatibility complex (MHC) in predisposition to familial ankylosing spondylitis (AS) [Abstract #1116]. Arthritis Rheum 2001; 44 (suppl.): 1111.
101. Khan MA, Akey J, Bruckel J, Weisman MH, Inman RD, Stone M, et al. HLA-DRB1*0101 and DRB1*1501 but not HLA-B60 (B*40:01) contribute to susceptibility to Ankylosing Spondylitis (AS) Arthritis Rheum 2002; 46 [No. 9 (suppl.)]: S435.
102. Reveille JD, Akey J, Bruckel J, Weisman M, Inman RD, Stone M, ----- Khan MA, ----- Jin L. Definite evidence for at least one other major histocompatibility complex (MHC) gene in addition to HLA-B27 in predisposition to ankylosing spondylitis. Arthritis Rheum 2002; 46 (No. 9 (suppl.)): S392.
103. Reveille JD, Akey J, Bruckel J, Weisman MH,…Khan MA, ..Jin L. The Interleukin Receptor-1 Antagonist (IL-1RA) gene is implicated in predisposition to ankylosing spondylitis (AS). Arthritis Rheum 2002; 46: No. 9(suppl.): S620.
104. Reveille JD, Akey J, Bruckel J, Weisman MH,…Khan MA, ..Jin L. Genetic studies of MHC and non-MHCgenes in familial ankylosing spondylitis (AS). 3rd International Congress on Spondyloarthropathies. October 2-5, 2002. Abstracts. Clinical and Exp Rheumatol. P. 590, 2002
105. Rudwaleit M, Braun J, Khan MA, van der Heijde D, Sieper J. Early diagnosis of ankylosing spondylitis. Ann Rheum Dis 2003; June (Suppl.), 54.
106. Yunus MB, Arnold L, Iyengar SK, Khan MA, et al. Associated Phenotypes in Familial Fibromyalgia Syndrome (FMS): A Preliminary Report from the Fibromyalgia Family Study Group (FFSG). Arthritis Rheum 2003; 48: #9 (suppl.), S86-S87.
107. Arnold LM, Iyengar SK, Khan MA, et al. Genetic linkage of Fibromyalgia to the Serotonin Receptor 2A Region on Chromosome 13 and the HLA region on Chromosome 6. Arthritis Rheum 2003; 48: #9 (suppl.), S228-S229
108. Lee J, Jingchun L, Bruckel J, Inman R, Mahowald M, Weisman M, Schumacher R, Khan MA, et al. A Genome Scan for Ankylosing Spondylitis Susceptibility. Arthritis Rheum 2003; 48: #9 (suppl.), S224.
109. Reveille JD, Lee J, Bruckel J, Weisman M, Khan MA et al. Fine Mapping of Candidate Susceptibility Regions in Ankylosing Spondylitis on Chromosome 11q. Arthritis Rheum 2003; 48: #9 (suppl.), S224.
110. Reveille JD, Lee J, Bruckel J, Weisman M, Khan MA et al. Fine Mapping of Candidate Susceptibility Regions in Ankylosing Spondylitis on Chromosome 6q25. Arthritis Rheum 2003; 48: #9 (suppl.), S224-S225.
111. Rudwaleit M, Braun J, Khan MA, van der Heijde D, Sieper J. How to diagnose spondyloarthritis early? Arthritis Rheum 2003; 48: #9 (suppl.), S174.
112. Reveille JD, Zhang G, Bruckel J, Weisman MH, Bruckel J, Schumacher, HR, Khan MA et al. The haplotype HLA-B*0700, DRB1*1501, DQA1*0102, DQB1*0602 augments the risk of the development of ankylosing spondylitis in addition to HLA-B27. Arthritis Rheum 2004 49: #9 (suppl.), S259.
113. Reveille JD, Zhang G, Bruckel J, Weisman MH, Bruckel J, Schumacher, HR, Khan MA et al. Interaction of a region on Chromosome 11q23 and the HLA-DPB1 locus influences susceptibility to ankylosing spondylitis. Arthritis Rheum 2004 49: #9 (suppl.), S449.
114. Martin TM, Zhang G, Luo J, ----, Khan MA et al. A region on Chromosome 9p predisposes to acute anterior uveitis, a specific disease manifestation in ankylosing spondylitis. Arthritis Rheum 2004 49: #9 (suppl.), S448-S449
115. Martin TM, Reveille JD, Smith JR, -------, Khan MA, Schumacher HR and Rosenbaum JT. The MHC class II haplotype HLA-DRB1*0801/DQA1*0401/DQB1*0402 is associated with acute anterior uveitis. Experimental Biology Meeting, April 2005
116. Zochling J, van der Heijde D, ------- Khan MA et al. ASAS/EULAR Recommendations for the management of ankylosing spondylitis. Ann Rheum Dis 2005 (EULAR Abstracts) (suppl.)
117. Rudwaleit M, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA et al. Assessment of Agreement of Expert Opinion on Clinical Features in Axial Spondyloarthritis (SpA). Arthritis Rheum 2005; 52: #9 (suppl.), S637.
118. Zochling J, van der Heijde D, ------- Khan MA et al. ASAS/EULAR Recommendations for the management of ankylosing spondylitis. Arthritis Rheum 2005; 52: #9 (suppl.), S638-S639.
119. Rudwaleit M, Landewé R, Brandt J, Burgos-Vargas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA et al. Parameters Contributing to Inflammatory Back Pain (IBP) According to Experts. Arthritis Rheum 2005; 52: #9 (suppl.), S213.
120. Reveille JD, Zhang G, Weisman MH, Bruckel J, Inman RD, Khan MA, et al. Evidence for Involvement of the Neural Cell Adhesion Cell (NCAM)-1 Gene in Susceptibility to Ankylosing Spondylitis. Arthritis Rheum 2005; 52: #9 (suppl.), S389.
121. Albuquerque SM, Zhang G, Zhou X, ---, Khan MA, et al. Association of IL-1 gene with ankylosing spondylitis susceptibility: Evidence from family based analysis. Late breaking abstract. Presented at the ACR 2005 Annual Scientific Meeting.
122. Braun J, Cook R, Landewe R, ---, Khan MA, et al. INSPIRE Lateral Flexion: A new method to measure lateral spinal mobility in patients with spondyloarthritis. Ann Rheum Dis 2006, 65 (Suppl 2), 208.
123. Gladman DD, Inman RD, Cook R, ---, Khan MA, et al. International Spondyloarthritis Inter-observer Reliability Exercise – the INSPIRE study. Ann Rheum Dis 2006, 65 (Suppl 2), 217.
124. Olivieri I, D’Angelo S, Cutro MS, --, Khan MA. Diffuse Idiopathic Skeletal Hyperosotosis. Ann Rheum Dis 2006, 65 (Suppl 2), 640.
125. Zhou X, Xiong M, Weisman MH, Inman RD, Khan MA, et al. Genetic studies of the Interleukin-1A, CTGF, DRB1, DQA1, DQB1, DPB1, HLA-B and HLA-A in multiple ankylosing spondylitis families. Arthritis Rheum 2007; ACR Annual Meeting Abstract suppl, p S45.
126. Gladman DD, Inman RD, Cook R, ---, Khan MA, et al. Composite indices for disease activity in ankylosing spondylitis and psoriatic arthritis. Arthritis Rheum 2007; ACR Annual Meeting Abstract suppl, p S481.
127. Weber U, Maksymowych WP, Jurik AG, Pfirrmann CWA, Kissling RO, Khan, MA, Hodler J. Validation of whole body MRI against conventional MRI for scoring inflammatory lesions in the sacroiliac joints of patients with spondyloarthritis. Presented at EULAR 2008 Meeting in Paris, France. Ann Rheum Dis 2008, (Suppl) and also presented at ACR Annual Meeting in San Francisco, October 24 – 29, 2008.
128. Weber U, Hodler J, Jurik AG, Pfirrmann CWA, Kissling RO, Khan, MA, Maksymowych WP. Validation of whole body MRI against conventional MRI for scoring inflammatory changes in the entire spine in spondyloarthritis. Presented at EULAR 2008 Meeting in Paris, France. Ann Rheum Dis 2008, (Suppl). It was also presented at the ACR Annual Meeting in San Francisco, October 24 – 29, 2008.
129. Mease P, Pangan AL, Deodhar AA, Khan MA, Rosenbaum JT, van der Heijde D, Sieper J, Combescure C, Dougados M. Characterization of Spondyloarthritis Diagnoses and Patient Satisfaction with Current Treatments in the US: Report from the SPARK Survey. ACR Annual Meeting in Philadelphia, 2009.
130. Kiltz U, van der Heijde, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a Health Index to Assess the Burden of Disease in Patients with Ankylosing Spondylitis: First Steps of a Global Initiative Based on the ICF Guided by ASAS. Abstract # OP0251. Presented at the Annual European Congress of Rheumatology EULAR 2012, Berlin, Germany, 6 – 9 June, 2012.
131. Bao C, Huang F, Khan MA, Fei K, Wu Z, Hsia EC. Golimumab Administered Subcutaneously Every 4 Weeks in Chinese Patients with Active Ankylosing Spondylitis: Week 24 Safety and Efficacy Results From a Randomized, Placebo-Controlled Study. Presented at the 15th Congress of Asia-Pacific League Against Rheumatism APLAR 2012. Dead-Sea, Amman, Jordan, 10-14 September, 2012.
132. Bao C, Huang F, Khan MA, Fei K, Wu Z, Hsia EC. Golimumab Administered Subcutaneously Every 4 Weeks in Chinese Patients with Active Ankylosing Spondylitis: Week 24 Safety and Efficacy Results From a Randomized, Placebo-Controlled Study. Presentation at 2012 ACR Annual Meeting, Washington, D.C., November 9-14, 2012.
Arthritis Rheum 2012; vol 63, No: 10 (suppl), p S589.
133. Magrey M, Khan MA. Utility of Dual-Energy X-Ray Absorptiometry Scanning and Risk of Osteoporosis in Ankylosing Spondylitis; A Prospective Study. Presentation at 2012 ACR Annual Meeting, Washington, D.C., November 9-14, 2012.
Arthritis Rheum 2012; vol 63, No: 10 (suppl), p S243-S244.
134. Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a Health Index for Patients with Ankylosing Spondylitis. Presented at 2012 ACR Annual Meeting, Washington, D.C., November 9-14, 2012. Arthritis Rheum 2012; vol 63, No: 10 (suppl), p S593-594.
135. Bao C, Huang F, Khan MA, Fei K, Wu Z, Hsia EC. Safety and Efficacy of Golimumab in Chinese Patients with Active Ankylosing Spondylitis 1- year Result of a Multicenter Randomized, Double-blind, Placebo-Controlled Study. 2013 EULAR (European Congress of Rheumatology) Annual Scientific meeting. June 14, 2013 in Madrid, Spain. And 2013 ACR Annual Scientific meeting. October 30, 2013 in San Diego, USA.
136. Kiltz U, van der Heijde D, Boonen A, Cieza A, Stucki G, Khan MA, et al. Development of a Health Index in Patients with Ankylosing Spondylitis (ASAS HI) – Final Results of a Global Initiative Based on the ICF Guided by ASAS. 2013 EULAR (European Congress of Rheumatology) Annual Scientific meeting. June 14, 2013 in Madrid, Spain. And 2013 ACR Annual Scientific meeting. Abstract # 2836. October 30, 2013 in San Diego, USA.
137. Kiltz U, van der Heijde, Boonen A, Cieza A, Stucki G, Khan MA, et al. Translation and cross-cultural adaptation of the ASAS Health Index and the Environmental Item set into 15 languages. Presented at the Annual European Congress of Rheumatology EULAR 2014, Paris, France. June 11-14, 2014.
138. Kiltz U, van der Heijde D, Boonen A, Bautista W, --------, Khan MA, et al. Translation and cross-cultural adaptation of the ASAS Health Index and the Environmental Item set into 15 languages. Presented at the 9th International Congress of Spndyloarthropathies. Gent, Belgium, October 23-25, 2014
139. Magrey M, Lewis S, Khan MA. Do the validated tools of disease and functional activity in ankylosing spondylitis measure fibromyalgia symptoms? Presented at the Annual European Congress of Rheumatology EULAR 2016, London, England. June 8-11, 2016.
140. Magrey M, Diamampo S, Khan MA. Do validated tools of disease activity in ankylosing spondylitis measure fibromyalgia pain? Presented at the 2016 ACR Annual Meeting, Washington, D.C., November 11-16, 2016.
141. van der Linden, Rentsch H, Baumberger H, Khan MA. Specificity of spinal pain features in assessment and classification of spondyloarthriis. Presented at the 2016 ACR Annual Meeting, Washington, D.C., November 11-16, 2016.
142. Baumberger H, Khan MA. Gradual progressive change to equal prevalence of ankylosing spondylitis among males and females in Switzerland: Data from the Swiss Ankylosing Spondylitis Society (SVMB). Ann Rheum Dis 2017;76:529. (Presented at the Annual European Congress of Rheumatology EULAR 2017, Madrid, Spain. June 14-17, 2017. Ann Rheumatic Dis. 2017; volune 76; suppl. 2; page 929.)
143. van der Linden, Villiger P, Boonen A, Brown MA, Baumberger H, Khan MA. The occurrence of ankylosing spondylitis (AS) among relatives of probands with radiographic AS and non-radiographic AS/axial spondyloarthritis (SpA). Presented at the Annual European Congress of Rheumatology EULAR 2017, Madrid, Spain. June 13-16, 2018.
WEB SITE: www.spondyloarthritis-international.org
www.HLAB27.com
www.spondyloarthritis.com
ONLINE PUBLICATIONS:
Khan MA: Editorial Consultant to American College of Physicians’ on-line ACP Smart Medicine (formerly called Physician Information and Education Resource or“PIER”) since 2002, and
author of the chapter “Ankylosing Spondylitis” and its updates from 2002 to 2015. www.smartmedicine.acponline.org
Khan MA: Editorial Consultant 2013-2016 to InPractice Rheumatology, an on-line knowledge source for internists, including rheumatologists.
Co-author of the chapter on “Spondyloarthritis”.
Medscape: Expert Column: Ankylosing spondylitis. Posted 09/28/2006. http://www.medscape.com/viewarticle/544971
Medscape: EUAR 2007: The Annual European Congress of Rheumatology. Ankylosing Spondylitis. An Update From EULAR 2007. http://www.medscape.com/viewarticle/560593
Medscape: EUAR 2007: The Annual European Congress of Rheumatology. Psoriatic Arthritis: An Update From EULAR 2007. http://www.medscape.com/viewarticle/560594
Medscape: EUAR 2007: The Annual European Congress of Rheumatology. EULAR 2007: Update on RA. PsA, and AS:. http://www.medscape.com/viewprogram/7518
Medscape: Online CME activity. Release Date: May 27, 2008; Valid for credit through May 27, 2009. Khan MA, Elyan M. The Many Faces of Ankylosing Spondylitis: Evidence-Based Approach to Diagnosis and Management, http://www.medscape.com/viewprogram/12637
Medscape: American College of Rheumatology (ACR) 2008 Annual Scientific Meeting. Spondyoarthropathies: Treatment Advances from ACR 2008, http://www.medscape.com/viewarticle/585026